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Abstract 
In our modern society we are exposed to many natural and synthetic chemicals. The 
assessment of chemicals with regard to human safety is difficult but nevertheless of high 
importance. Beside clinical studies, which are restricted to potential pharmaceuticals only, 
most toxicity data relevant for regulatory decision-making are based on in vivo data. Due 
to the ban on animal testing of cosmetic ingredients in the European Union, alternative 
approaches, such as in vitro and in silico tests, have become more prevalent. 
In this thesis existing non-testing approaches (i.e. studies without additional experiments) 
have been extended, e.g. QSAR models, and new non-testing approaches, e.g. in vitro 
data supported structural alert systems, have been created. The main aspect of the thesis 
depends on the determination of data quality, improving modelling performance and 
supporting Adverse Outcome Pathways (AOPs) with definitions of structural alerts and 
physico-chemical properties. Furthermore, there was a clear focus on the transparency of 
models, i.e. approaches using algorithmic feature selection, machine learning etc. have 
been avoided. Furthermore structural alert systems have been written in an 
understandable and transparent manner. Beside the methodological aspects of this work, 
cosmetically relevant examples of models have been chosen, e.g. skin penetration and 
hepatic steatosis.  
Interpretations of models, as well as the possibility of adjustments and extensions, have 
been discussed thoroughly. As models usually do not depict reality flawlessly, consensus 
approaches of various non-testing approaches and in vitro tests should be used to support 
decision-making in the regulatory context. For example within read-across, it is feasible 
to use supporting information from QSAR models, docking, in vitro tests etc. By 
applying a variety of models, results should lead to conclusions being more 
usable/acceptable within toxicology. 
Abstract 
 
 
Within this thesis (and associated publications) novel methodologies on how to assess 
and employ statistical data quality and how to screen for potential liver toxicants have 
been described. Furthermore computational tools, such as models for skin permeability 
and dermal absorption, have been created.  
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1. Introduction 
1.1. Safety assessment of chemicals 
As modern society demands a safer environment, the assessment of the harmful effects of 
chemicals has become a crucial element of today’s toxicology. The desire for the use of 
safe chemicals arises, in part, from a consumer perspective, which includes the 
requirement for safety of pesticides, foods, pharmaceuticals, cosmetics, industrial 
chemicals etc. It also arises within occupational health, i.e. for the assessment of workers 
who are exposed to chemicals in an industrial setting, or it may come from an 
environmental perspective, for example the effects of chemicals on flora, fauna, and 
ultimately humans, via the food chain. Advances in technology in the last century have 
led to an intensive production of drugs, cosmetics, food products, pesticides, munitions, 
synthetic fibres and industrial chemicals (Gallo, 2001; Cronin, 2013). There are many 
other, often less recognised, sources of chemicals to which we are exposed; substances 
may originate, for example, from fungi, botanicals or from the petro-chemical industry 
(including their combustion products). Chemicals exposure may be localised or might be 
long-range, for instance transportation via air pollution (Alam et al., 2013) or via the food 
chain (Cheng et al., 2015a). 
The number of potential organic chemical compounds is almost unimaginably large, and 
it is impossible to limit exposure of chemicals per se as we live in a world made of 
chemicals. Despite this, the toxicological/pharmacological effects are known for only a 
very small proportion of chemicals, even for commonly used compounds (Cronin, 2013). 
As a result it is difficult to ensure the safety of chemicals, or the absence of associated 
adverse effects. Exposure to many chemicals, pharmaceuticals and pesticides being the 
most active/extreme examples, is controlled through national regulations. It is the purpose 
of regulatory authorities, such as the US Food and Drug Administration (FDA), to assess 
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chemicals for their safety by gathering knowledge from experimentation (or non-test 
methods), feedback from human exposure and utilising human expertise to evaluate the 
data enabling risk assessment. Thus regulators use toxicological information on specific 
substances to define thresholds, which are thought to be safe to man and the environment 
for the intended use of the chemical (Merrill, 2001). It is important to distinguish between 
contaminants and compounds used deliberately in food or cosmetic products, e.g. 
preservatives. For the latter, there is usually more information available, for example how 
to detect them analytically or the principal effects they have on biological systems. 
Contaminants or impurities, on the other hand, vary widely in terms of chemistry and are 
often dependent from educts used and/or the manufacturing process (Gallo, 2001; Merrill, 
2001; Feigenbaum et al., 2015), they may also be as a result of compound degradation 
(biotic or abiotic). Despite the many substances created unknowingly within the 
manufacturing process, mostly in low concentrations or even traces, a great number of 
chemicals (and mixtures) are produced wittingly. These substances can be ingredients for 
consumer products or intermediates made for further chemical engineering (Faustman 
and Omenn, 2001). 
In the context of better risk assessment for the higher production volume chemicals, the 
Registration, Evaluation, Authorisation and restriction of CHemicals (REACH) 
regulation, which is enforced by the European Union and regulated by the European 
Chemicals Agency (EChA), has been an immense undertaking for over a decade. 
REACH addresses production quantity and use of chemicals and their potential impacts 
on human and environmental health. Here the focus lies on evaluating chemicals, and 
particularly those produced in large quantities, e.g. greater than ten tonnes per year (EC, 
2006). For the appropriate evaluation of chemicals, not only within the context of 
REACH, a sound understanding of toxicology and exposure is needed.  
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1.2. Toxicology and its application 
Toxicology is the science of poisons. It is a centuries old scientific discipline, with the 
thoughts of the Swiss physician/alchemist Paracelsus from the 16th century still relevant 
today. Paracelsus stated that any substance can be poisonous, only the dose differentiates 
the non-poisonous from the poisonous. This statement gives rise to our understanding that 
the intrinsic risk of a chemical is a function of its implicit hazard and the exposure 
scenario, as such toxicology reveals itself as a non-trivial task (Gallo, 2001). Historically 
toxicology is an experimental and observational science with the use of animals to 
identify hazard at the heart of most studies. Some of the more common, and relevant to 
this thesis, toxicological procedures that have been used for hazard identification are 
introduced below.  
1.2.1. Acute toxicity 
A standard way to measure acute toxicity (normally associated with lethality) is the LD50 
(the single dose of a substance that causes death in 50% of an animal population). These 
values, usually extracted from a dose-response-curve, allow for the differentiation of 
those chemicals with high acute toxicity from chemicals with low acute toxicity. 
However, acute toxicity may be influenced by many (non-chemically related) factors 
such as dosing regime and route, species, age, weight and sex. However lethality, as in 
LD50, is not the only endpoint of interest when performing acute toxicity animal testing. 
Doses and exposure patterns, where for example blood chemistry or kidney and liver 
histology is pathologically changed, can reveal potential risks of chemicals and form the 
basis of long-term studies (Barile, 2004).  
1.2.2. Chronic toxicity 
In addition to testing for acute toxicity (i.e. short-term, high dose exposure, with the aim 
of identifying a lethal dose), there is also a great interest in non-lethal effects and toxicity 
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caused by repeated dose exposure. Chronic or repeated dose toxicity is caused by long-
term, continuous or fluctuating sublethal exposure of a toxicant. Typical repeated dose 
exposure scenarios are subacute, subchronic or chronic, and definitions and exposure 
guidelines for these may vary. This may be particularly important for substances which 
have a long half-life and a tendency to be accumulated and reveal adverse effects after 
long-term exposure (Barile, 2004). In addition, identifying the relevant mechanistic 
pathways and kinetics associated with chronic toxicity is a complex, but increasingly 
important, task. Further, there are compounds which interfere at low doses with the 
human hormonal system, such as endocrine disruptors, which are likely to cause 
pathological changes when exposed chronically (Fuhrman et al., 2015). 
 
1.2.3. Other effects  
Further genotoxicity (e.g. due to mutagenicity) and immunotoxicological responses are of 
great interest for applied toxicology and risk assessment as these can be triggered by very 
low doses (Faustman and Omenn, 2001; Barile, 2004). These may be identified by 
specific, often mechanistically derived, tests such the Ames test for genotoxic 
mutagenicity. These effects are outside the scope of this thesis and are not considered 
further.  
 
1.2.4. Experimental considerations when testing 
When assessing the experimental determination of toxicity, the route of administration, 
e.g. topical, oral, inhalation or subcutaneous, intravenous and intramuscular injection, and 
the formulation of the drug/toxicant (i.e. particle size, excipients etc.) are important 
parameters. While an intravenous dose of a drug is usually systemically available, an oral 
dose is most often absorbed more slowly through the gastrointestinal tract and eventually 
metabolised, for example by the first-pass effect (and further metabolism by repeated 
passing through the liver). Further novel formulations can deliver drugs to specific target 
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tissues, e.g. drug-loaded nanoparticle systems. Hence, both route of administration and 
formulation play important roles for the absorption, distribution and finally the biological 
effects of a drug/toxicant. These lessons, which were mainly learnt in the field of 
pharmacology, are of great importance for understanding and applying modern 
toxicology (Rang et al., 2007a; Barile 2004). The correct dosing route is also essential to 
understand the effects of a particular exposure scenario, i.e. a pharmaceutical applied as 
an oral dosage form should be tested orally in an attempt to mimic (within reason) the 
kinetics of uptake, distribution and metabolism. 
 
1.2.5. Data availability  
It has historically been a great problem to obtain appropriate, high quality and relevant 
toxicity data for a variety of chemicals. It is assumed that many of the available toxicity 
data are in private hands, e.g. within pharmaceutical companies (Cases et al., 2013; 
Tralau et al., 2015). While there are often many data for acute toxicity, e.g. LD50 values 
for rodents, and local (adverse) reaction, such as skin and eye irritation, there is a lack of 
publically available data and hence a shortcoming in understanding of biological 
responses associated with chronic toxicity. The ever increasing number of chemicals 
produced and the introduction of expectations, such as reducing or replacing animal 
testing, is the setting for 21st Century Toxicology (Cronin, 2013; Groh et al., 2015; 
Vinardell, 2015). Within this thesis (e.g. Chapters 2 and 3) efforts to supplement the 
availability of chronic toxicity data, as well as understand the quality of data, are 
presented in response to this need.  
 
1.2.6. Application of toxicological information 
There are many applications of toxicological information, but for the purposes of this 
thesis risk assessment, relating to regulatory acceptance of a chemical, is considered in 
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more focus, as introduced in Section 1.3. A further application of toxicological 
information is the requirement to find ethical, cost-effective and scientifically valid 
alternatives to animal testing that has been a driving force behind the research reported in 
this thesis; more details on this are given in Section 1.4. 
 
1.3. Regulatory toxicology 
Regulatory toxicology is a discipline which is intended to ensure that the world, in 
chemical terms, becomes a safer place. It combines toxicological expertise, i.e. 
knowledge of exposure, kinetics and mechanisms, with risk assessment approaches to 
create regulations. Regulatory toxicological activities take place partially in industry, e.g. 
companies launching new consumer products, and partially in governmental institutions. 
Taking the US as an example, the FDA is the responsible governmental institution for 
licensing food and medical products, such as drugs. Cosmetics do not need a license per 
se, but still they need to be regarded as safe before launching a product, i.e. potentially 
hazardous chemicals have to be excluded by regulatory toxicologists. With regard to 
human and environmental health, the US Environmental Protection Agency (EPA) is 
responsible for the assessment of the impact of pesticides or industrial chemicals and 
their exposure to man and environmental species (Merrill, 2001). In Europe there are 
institutions, such as the European Medicines Agency (EMA) and the European 
Environment Agency (EEA), with similar responsibilities as FDA and EPA respectively. 
National regulations of EU member states still may vary, for example due to 
recommendations from domestic institutes, e.g. the German Federal Institute for Risk 
Assessment (Bundesinstitut für Risikobewertung; BfR). 
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1.3.1. Safety and legislation 
When assessing safety for different types of products, it is important to consider 
individual risk-benefit ratios. Drug safety for example, often dictated by therapeutic 
necessities, has a quite unique and complex way of considering the risk-benefit ratio for 
potential patients. This consideration is inevitably associated with the process of 
regulatory approval of pharmaceutical drugs. Generally, pharmaceutical drugs have to 
pass many stages before being launched for therapeutic purposes. After many years of 
drug development and preclinical testing (based on animal trails), only a few drug 
candidates will enter the clinical phases. All three clinical phases need to be passed 
consecutively, whereupon the last phase (clinical phase III) would be a multi-centred trial 
with 1,000 to 3,000 patients. Only after that, can a drug be submitted to regulatory 
authorities for licensing. Following the launch of a new drug post-market surveillance 
(often referred to as pharmacovigilance or phase IV) is the responsibility of the 
pharmaceutical company; this means monitoring the drug for adverse drug reactions and 
side effects, and withdrawing a drug from the market, should the need arise (Merrill, et al. 
2001; Barile, 2004; Rang et al., 2007b). 
Legal requirements for non-pharmaceutical products, such as biocidal and plant 
protection products (e.g. pesticides), food products and diverse consumer products (e.g. 
toys, textile products) can be quite different. In food safety, for example, food additives, 
flavouring substances, novel ingredients, genetically modified organism-based products 
and contaminants need to be assessed as being safe before bringing them onto the market. 
The legal responsibility for consumer goods usually lies with the producing company. 
With regard to the safety assessment of biocidal and plant protection products, the legal 
focus lies on metabolites in food, feed and groundwater, and the assessment of 
cumulative effects in organism and soils (Tralau et al., 2015). 
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1.3.2. The cosmetics legislation 
According to the European Cosmetics Regulation, a cosmetic product made available on 
the market has to be safe for humans when used normally and reasonably. Hence, the 
Cosmetic Directive places the responsibility for product safety clearly on the company. 
Nevertheless, the Scientific Committee on Consumer Safety (SCCS) provides the 
European Commission (EC) with scientific advice on the safety of cosmetic products (EC 
2009; Vinardell, 2015). 
Generally cosmetic ingredients should be inert, i.e. they should not have any significant 
pharmacological or toxicological properties. Of course, there are exceptions such as, for 
example zinc pyrithione, a fungi-/bacteriostatic substance used in antidandruff shampoo 
(Marks et al., 1985), or hair dyes, such as aromatic azo dyes, which can act as 
mitochondrial toxins (Nelms et al., 2015). Compounds of concern are often found in the 
functional classes associated with colourants, preservatives and UV filters. However, 
exposure, i.e. dose and type of application, plays an important role for the risk assessment 
of a cosmetic ingredient. In other words, considering the quantity and type of usage is 
also the responsibility of industry and regulatory authorities (e.g. through the SCCS in the 
EU) (Vinardell, 2015). 
Since March 2013, European legislation has banned animal testing for any cosmetic 
ingredient marketed within the EU (EC, 2009). Proposed alternative testing methods 
include in vitro tests (e.g. mechanistically based mutagenicity assays) and in silico 
approaches (such as computational methods, often based on historical in vivo toxicity 
data). Current challenges revolve around the need for alternatives, especially for chronic 
and reproductive toxicity (Adler et al., 2011). Examples where successfully validated 
alternatives are present are the local lymph node assay (LLNA) used for skin sensitisation 
and diverse alternatives for the Draize rabbit eye test to evaluate of eye irritation. 
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However, current alternative methods still have potential for optimisation, particularly as 
some of the methods are ex vivo assays (i.e. using tissues of animals) and hence animals 
are still used for testing (AltTox, 2015; Roberts, 2015; Vinardell, 2015). 
Whilst modern animal welfare is often considered to be driven by companies, such as 
Lush (Lush, 2015) and organisations, such as the People for the Ethical Treatment of 
Animals (PETA, 2015), there have been attempts to reduce the number of animals used 
and to generally increase animal welfare standards for more than fifty years. For example 
Russell and Burch’s “3Rs”, which refers to the replacement, reduction and refinement of 
animal tests, is a paradigm, which has existed since the late 1950s (Russell and Burch, 
1959). Considerable success regarding the 3Rs has already been seen within the 
approaches adopted by institutions such as the Organisation for Economic Co-operation 
and Development (OECD). The OECD aims to stimulate economic progress and world 
trade within a democratic and capitalistic framework, coined by its European and 
American member states. They play an important role by providing international 
guidelines, not only in the field of toxicology. For instance, included within the OECD 
test guideline for acute eye irritation/corrosion (OECD, 2012), the usage of topical 
anaesthetics and systemic analgesics is described with the aim to decrease animal 
suffering. Furthermore, tests such as reduced LLNA (rLLNA), which uses fewer 
experimental animals as compared to the conventional LLNA (itself a less invasive test 
using fewer animals than the guinea pig maximisation tests), are promoted (Roberts, 
2015). However, despite the importance of assessment of skin sensitisation for dermally 
applied products, it must be pointed out that the rLLNA is an in vivo assay, i.e. novel 
cosmetic ingredients tested with the rLLNA would not be allowed for sale in the EU 
according to the EC’s Cosmetics Directive (EC, 2009). 
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1.3.3. The European Commission’s role 
The EC plays an important role in the advance of alternative testing methods, most 
notably with the SEURAT-1 “Safety Evaluation Ultimately Replacing Animal Testing” 
cluster. SEURAT-1 is a 50 million euro project funded by EC’s Seventh Framework 
Programme (FP7) and Cosmetics Europe, the European trade association for cosmetic, 
toiletry and perfumery industry. Within SEURAT-1, for five years (2011-2015), research 
facilities from industry and over 70 European universities and SMEs have been 
developing non-animal test methods for systemic toxicity following repeated exposure 
etc. The SEURAT-1 cluster is divided into seven distinct projects (Gocht and Schwarz, 
2014; SEURAT-1, 2015): 
 SCR&Tox, “Stem Cells for Relevant efficient extended and normalised 
Toxicology” 
 HeMiBio, “Hepatic Microfluidic Bioreactor” 
 DETECTIVE, “Detection of endpoints and biomarkers of repeated dose toxicity 
using in vitro systems” 
 COSMOS, “Integrated in silico models for the prediction of human repeated dose 
toxicity of COSMetics to Optimise Safety” 
 NOTOX, “Predicting long-term toxic effects using computer models based on 
systems characterisation of organotypic cultures” 
 ToxBank, “Supporting integrated data analysis and servicing of alternative testing 
methods in toxicology” 
 COACH, “COordination of projects on new Approaches to replace current 
repeated dose systemic toxicity testing of cosmetics and CHemicals” 
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One of the research projects within the SEURAT-1 cluster is the COSMOS Project. As 
the full title and semi-acronym, “Integrated in silico models for the prediction of human 
repeated dose toxicity of COSMetics to Optimise Safety” indicates, the project aims to 
develop computational methods. Computational methods demand sufficient data, the 
requirement for which is often neglected, but is actually a crucial part for any data-driven, 
scientific approach. Therefore, building a database relevant for cosmetics was one of the 
major objectives of COSMOS. The so-called “COSMOS DB” was released online as a 
freely available resource in December 2013. This database can be regarded as the 
backbone for modelling and read-across approaches used to assess cosmetic ingredients 
within COSMOS (Richarz et al., 2014). 
In addition, the refinement of the Toxicological Threshold of Concern (TTC) approach 
and its extension to cosmetics ingredients is a major aim of the COSMOS project. As 
humans are likely to be exposed to thousands of chemicals in their life-time, and it is 
impossible to test every compound against every possible endpoint, feasible and 
pragmatic approaches for risk assessment are necessary. Originally deriving from the 
food industry, the TTC approach applies margins of safety based on no-observed-effect 
levels (NOELs), i.e. the highest concentration of a substance not causing any toxic effects 
in vivo. The so calculated acceptable daily intake (ADI) should ensure consumer safety 
(Munro et al., 1996; Richarz et al., 2014; Feigenbaum et al., 2015). 
Many challenges of the COSMOS project lie within the field of kinetics, i.e. predicting 
dermal absorption and modelling the distribution of chemicals (refer to physiologically-
based pharmacokinetic models). The distribution of a chemical within tissues is of 
particular interest regarding potential target organ toxicity. Besides kinetic aspects, 
specific mechanisms of toxicity were also investigated within COSMOS (Richarz et al., 
2014). For example, many mechanisms of toxicity have been identified lately within the 
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Adverse Outcome Pathway (AOP – described in Section 1.4.2) framework (Vinken et al., 
2013).  AOP-related QSAR models, for example for compounds causing fatty liver 
(hepatosteatosis) via agonism of the liver X receptor (LXR; a nuclear receptor 
responsible for lipid regulation amongst others), are under development (Fioravanzo et al., 
2013; Richarz et al., 2014). Further screening tools for hepatotoxicity based on structural 
alerts and/or physico-chemical properties have been developed within the COSMOS 
project (e.g. Nelms et al., 2015, Steinmetz et al., 2015a). 
 
1.4.  21st Century Toxicology 
There are many international endeavours, including projects within the Horizon2020 
funding programme in Europe and Tox21 in the US, to elucidate toxicity pathways at a 
molecular, cellular and histological level. By employing systems biology, i.e. genomics, 
proteomics and metabolomics, and robot-supported quantitative high-throughput 
screening (qHTS), a large amount of data are, and will be, generated (Attene-Ramos et al., 
2013; Gaspar et al., 2012). Tox21, for example, screens chemicals using over 75 
biochemical and cell-based assays resulting in information for different perturbations of 
signalling pathways, inflammatory response induction, DNA damage, general 
cytotoxicity etc. If these, and the associated existing in vivo / clinical, data are interpreted 
well, a significant wealth of knowledge could be created and exploited for 
pharmacological research and toxicological risk assessment. One such example is the 
work of Attene-Ramos and colleagues regarding mitochondrial toxicity; they defined 
chemical (sub)structures responsible for decreasing mitochondrial membrane potential 
(Attene-Ramos et al., 2015). 
Overall the pharmacological and toxicological knowledge obtained from research 
projects, such as Tox21, will lead to new biomarkers, safer drugs and, in general, a 
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deeper understanding of biochemical interactions in vivo, which would benefit many life-
science disciplines and regulatory bodies (Gaspar et al., 2012; Attene-Ramos et al., 2013). 
  
1.4.1. Alternatives to animal testing 
Animal testing is usually a means to obtain information regarding the safety (or specific 
effects) of chemicals relevant to humans. Human trials, which per se would provide more 
relevant data, are generally regarded as unethical and limited to clinical trials, patch tests 
etc., where mostly non-toxic doses are administered. Within 21st Century Toxicology 
animal testing is becoming regarded as unethical, and even lacking scientific credibility, 
leading to alternative methods being investigated (Russell and Burch, 1959). SEURAT-1 
is a good example how toxicological research can be conducted without animal testing, 
i.e. batteries of different in vitro tests on the one hand and computational modelling on 
the other. 
Similar to species differences in susceptibility towards different chemicals, in vitro to in 
vivo extrapolation is a difficult challenge. Approaches for alternative test methods 
principally come from in vitro studies, e.g. the hepatic microfluidic bioreactor – a 
simulation of the human liver, and in silico studies, mainly in the form of 
physiologically-based pharmacokinetic (PBPK) models predicting target organ 
concentrations of chemicals (Gocht and Schwarz, 2014; SEURAT-1, 2015). Furthermore 
there are non-testing approaches aiming to make predictions of toxicity directly from 
chemical structure and property, mainly based on QSAR, read-across and expert opinions, 
which are sometimes summarised under the banner of predictive toxicology. 
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1.4.2. Predictive toxicology 
Predicting the toxicity of an untested chemical is of great interest for many different 
reasons, such as animal welfare, or simply to save the costs of testing and resources 
involved. Whatever the motivation is, similar methods are applied. Better known methods 
include Quantitative Structure-Activity Relationship (QSAR) models and the read-across 
(also known as the category formation) approach. While QSAR models are usually based 
on one or more mathematical equation(s) exploiting physico-chemical and other 
descriptors to predict toxic effects, read-across, as the name suggests, is a direct 
extrapolation of toxicological effects from structurally similar compounds, usually 
performed by experts (Cronin, 2004; Cronin, 2013a; Schultz et al., 2015). Further the 
concept of the Adverse Outcome Pathway (AOP), i.e. describing a sequence of causally 
linked events at different biological levels, is increasingly used to predict toxicity 
(Vinken et al., 2013; Vinken, 2015). An AOP is shown schematically in Figure 1.1; the 
first key event of an AOP, the molecular initiating event (MIE) is followed by cellular 
and tissue responses, which may ultimately result in an adverse effect to an organ, 
organism or population (Ankley et al., 2010). The MIE represents the initial interaction 
between molecule and the target and hence represents a significant source of information 
to develop structure-activity relationships (SARs) as part of mechanistically based 
computational profilers for toxicity. Examples of MIEs include covalent binding to DNA 
and receptor binding (Gutsell and Russell, 2013; Allen et al., 2014). The AOP framework 
is, for example, used in Chapter 5 and 6 to predict potentially toxic compounds. 
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Figure 1.1: Schematic view of the Adverse Outcome Pathway framework (adapted from   
Ankley et al., 2010) 
 
Computational approaches, sometimes referred to as in silico testing or virtual screening, 
are often based on QSAR models, which incorporate physico-chemical and structural 
features in a mathematical context towards an endpoint. Endpoints which have been 
successfully modelled by predictive QSAR models include acute aquatic toxicity 
(Könemann, 1981; Verhaar et al. 1996), hERG (human Ether-à-go-go-Related Gene)-
related toxicity (Gavaghan et al., 2007), mutagenicity (Benigni and Giuliani, 1994), skin 
permeability (Potts and Guy, 1992) and skin sensitisation (Roberts and Williams, 1982). 
Naturally QSAR models have been applied to numerous other endpoints and in many 
other disciplines too, e.g. receptor binding within drug development. However what 
makes the models developed for aquatic toxicology, hERG-related binding, mutagenicity, 
skin sensitisation and permeability so significant, is that the models are robust and 
applicable to a large variety of chemical compounds. QSAR models within a specific 
class of compounds, i.e. having a narrow applicability domain, are often referred to as 
local QSARs.  
The logarithm of the octanol-water partition coefficient (log P) plays an important role in 
many QSAR models, such as in aquatic toxicology and skin permeability, (refer to Potts 
and Guy, 1992; Verhaar et al., 1996). Log P, also known as log KOW (particularly in 
environmental sciences), is a measure of lipophilicity and hence is assumed to be an 
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excellent surrogate for the partitioning and uptake of a compound through a biological 
membrane. As well as experimentally measuring log P, it is well predicted from 
topological descriptors or structural fragments (Ognichenko et al., 2012). 
As recognised in the late 19th Century by Charles Richet who stated “plus ils sont 
solubles, moins ils sont toxiques” (the more soluble they are, the less toxic they are), the 
relationship of biological effects and water-insolubility of chemical compounds is very 
well established (Richet, 1893). With regard to pharmacology and what characterises an 
orally bioavailable drug, log P is an often mentioned parameter. The rationale is mostly 
based on simple kinetics, such as passive diffusion, e.g. log P is used to describe the 
ability of a compound to pass through a biological membrane (Lipinski et al., 2001), but 
there are mechanistic rationales too, such as the binding affinity towards receptors and 
transporters (refer to hydrophobic binding pockets) (Caron and Ermondi, 2008). QSAR 
approaches, particularly involving log P, are used, for example, in Chapters 2 and 3. 
Predictive toxicology does not have limitations regarding the techniques applied in order 
to obtain the predictions of toxicity. That is why a wide range of methods, from machine 
learning to local QSARs and expert systems, is applied and investigated (nota bene: 
many approaches are combinations of different methods). 
 
1.5. Aims of this work 
Two worlds often collide in modern society; the commercial and the consumer world. 
Here the commercial world, predominantly backed by large global industries, is 
supplying the consumer’s demand for innovative, safe and affordable consumer products. 
This includes products such as pharmaceuticals, cosmetics, clothing, toys and food. 
Within a capitalistic competitive environment it is important to deliver a product with an 
acceptable safety profile without compromising costs and/or quality. From a chemical 
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perspective, new compounds, ideally cheap to produce and functional, need to be 
assessed regarding their safety. As explained above, this is no easy task. To add a further 
challenge to this task; animal tests are banned for new cosmetic ingredients marketed 
within the European Union. In a nutshell, there is a high demand for in vitro and in silico 
methods applicable for safety and risk assessment. Regarding in silico methods, the work 
presented in this thesis is a contribution to the current state-of-the-art. The following 
topics are addressed within this thesis. 
- Data quality: Data are often erroneous for many reasons. However, having the 
appropriate quality of data is crucial for modelling and read-across. In particular,  
biological data (in comparison to physical or chemical data) are often associated 
with considerable error due to the complexity of assays and the difficulty of 
assigning endpoints. For example, a pharmacological dose-response relationship 
involves the formulation, dosing and administration of a substance to a group of 
animals, measuring a biological endpoint and applying statistical analysis to 
obtain an ED50 value. To overcome these potential pitfalls, large datasets have 
been investigated by statistical means to build tools for an unbiased way to assess 
data quality (refer to Chapter 2 and 3). 
- Kinetics: Pharmaco- and toxicokinetics, which by definition encompass 
absorption, distribution, metabolism and elimination of a xenobiotic substance, 
are of great importance for the assessment of safety of chemical compounds. For 
cosmetics, in particular, skin permeability and dermal absorption are of great 
interest as many products are applied dermally, e.g. shampoo, skin cream, make-
up. Approaches, such as those proposed by Lipinski et al. (2001) for oral drug 
absorption and Potts and Guy (1992) for skin permeability, have been refined and 
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adjusted towards 21st Century Regulatory Toxicology challenges, to support 
regulatory decision-making (refer to Chapters 3 and 4). 
- Mechanistically based modelling: There is a myriad of different modes of action 
in the area of toxicology. For example genotoxicity, including mechanisms such 
as DNA adduct formation, and different enzyme- and receptor-mediated toxicities, 
very often extensions of pharmacological research, have been investigated in the 
last century. Highly relevant to cosmetics is hepatotoxicity caused by chronic 
exposure. Different mechanisms of toxicity have been studied in this thesis, 
especially nuclear receptor interaction associated with hepatosteatosis. Ligands 
for these receptors can lead to adverse effects even if absorbed in small quantities 
– particularly if absorbed over an extended time period. Therefore large in vitro 
datasets have been investigated additionally to in vivo and clinical data to develop 
screening tools for potential hepatotoxicants (refer to Chapters 5, 6 and 7). 
Beyond the models and tools built, an overall aim is to propose ideas how to build 
and interpret new models, and of course how to use them in combination to support 
safety assessment in the consumer care industry. This research has been undertaken 
within the COSMOS project and hence, it is funded by the European Commission and 
Cosmetics Europe. 
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2. Methods for assigning confidence to toxicity data with multiple 
values – identifying experimental outliers* 
2.1. Introduction 
High quality data are preferred for model development in predictive toxicology. They are 
also required as a benchmark in the assessment of alternative assays and to enable 
analysis of toxicological pathways. Recently, further toxicity data have become available 
through sources such as the OECD QSAR Toolbox, release of information from dossiers 
submitted to the ECHA, the OECD eChemPortal and many other sources (Cronin and 
Schultz, 2003; Fourches et al., 2010; Przybylak et al., 2012; Péry et al., 2013).  
When using these expanding resources of toxicity data for risk assessment purposes and 
modelling, the quality and reliability of the data must be assessed. For instance, a given 
dataset could be too “poor” in terms of quality for QSAR modelling but still satisfactory 
for the prioritisation of chemicals for testing or regulatory classification and labelling. 
Whilst QSAR modelling is dependent on a sensitive statistical analysis, e.g. multivariate 
regression, to define reasonable descriptors, regulatory use of toxicity data may only need 
a rough estimation of hazard as a worst-case assumption, with extrapolation factors being 
applied (Nendza et al., 2010). 
Reliability is the measure of the extent of repeatability and reproducibility of a toxicity 
test for a particular chemical (OECD, 2003). As repeatability and reproducibility are not 
known for most data, a variety of approaches to assign reliability and confidence are used. 
Assessing data quality in predictive and computational toxicology is, however, a difficult 
task (Klimisch et al., 1996; Przybylak et al., 2012; Yang et al., 2013). There are a number  
 
* This chapter is based on a published article (Steinmetz et al., 2014) 
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of established criteria to ascertain the reliability of toxicity data. The most commonly 
applied are those proposed by Klimisch et al. (1996). These authors discussed data 
attributes such as reliability, relevance and adequacy and provided a scoring system to 
categorise data into reliability classes: 
 
1. reliable without restriction 
2. reliable with restrictions 
3. not reliable 
4. not assignable 
 
Przybylak et al. (2012) applied the Klimisch scheme and an updated scoring approach, 
based on ECHA guidance on information requirements and chemical safety assessment, 
to “real life” problems of toxicity data harvesting. In this work, the focus was on 
availability of information, consistency of study design, adherence to Good Laboratory 
Practice (GLP), test chemical identity and toxicological data. 
Whilst reliability (the backbone of an experiment and the resulting toxicity data), and 
relevance (the usefulness of the resulting data for the desired purpose such as risk 
assessment) in principle require interpretation by experts, the determination of the 
reliability of data can be as well supported by methods of “weighting” the data (Klimisch 
et al., 1996; Przybylak et al., 2012; Yang et al., 2013). When dealing with large sets of 
toxicity data, from multiple sources, there is often more than a single data entry for each 
compound. In this investigation these data entries are referred to as “conflicting data”. 
Even for a well-defined assay such as the acute fish toxicity test, considerable variability 
in potency is seen within the results for the same compound (Hrovat et al., 2009). If 
toxicity data are to be extracted for modelling from the increasing number of databases 
then criteria to identify reliable values are required. In particular, it would be helpful to be 
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able to score data for reliability. In this way, it may be possible to rationally combine 
what may be considered to be low quality data to obtain a more reliable score. 
Another interesting aspect of the quality control and assurance of toxicity data was 
investigated by Ruusmann and Maran (2013) who undertook an extended data harvest for 
the Tetrahymena pyriformis inhibition of growth assay (the Tetratox assay). They 
analysed the “timelines” associated with the reporting of chemical structures and 
experimental data and so examined when, and how, certain data were reported in the 
scientific literature over time. These authors came to the conclusion that mathematical 
manipulation (rounding, building averages etc.) and, of course, human error has led to 
differences in the data reported. For some compounds, there are many toxicity data from 
the same test; there is, however, no unified strategy to select which of the data to use, or 
how to use them. Often these toxicity data for the same compound have a normal 
distribution that makes it relatively easy to define a representative value via the median or 
arithmetic mean. Data which fall outside the normal distribution may be termed “data 
outliers”, i.e. they may be subject to considerable experimental error. Figure 2.1 
illustrates the issues of the presence of a data outlier in reducing certainty in the 
calculation of the mean or median.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Normal bell-shaped distribution bell for a sample dataset (representative EC50 values 
for different sources for one compound) with an “optimal” normal distribution (A) and with a 
dataset containing an outlier in the upper range (B) demonstrating the skew it may bring to the 
distribution in addition to the elevated Standard Deviation (StDev) 
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In principle, the arithmetic mean is a good way to consolidate associated data points to a 
single value. Here, every data point is taken into consideration, in equal parts, to build a 
new value – the arithmetic mean. In contrast the median is the middle value of a 
distribution. When dealing with high individual spreads, the median is the more stable 
approach (Rowe, 2007).  
Confidence scoring is based on the number and variability of conflicting data. In this 
context, the relative standard deviation (RSD; sometimes referred as coefficient of 
variation), as a quotient of standard deviation and arithmetic mean, expresses the 
variability of a dataset of toxicity values for one compound (Rowe, 2007). Thus a high 
number of entries per compound and a low RSD lead to high confidence and vice versa. 
In order to investigate the role of variability in toxicity databases and explore the 
possibility of applying statistical approaches to identify reliable toxicity data, historical 
toxicity data, measured in the Microtox assay (and its precursors), were considered. Such 
data have been published since the early 1980s (e.g. Dutka and Kwan, 1981; Chang et al., 
1981; Bulich et al., 1981; King and Painter, 1981; Curtis et al., 1982; Yates and Porter 
1982; DeZwart and Slooff, 1983; Ribo and Kaiser, 1984) and by the company Beckman 
Instruments, Inc. (now Beckman Coulter, Inc.). The Aliivibrio fischeri toxicity assay 
(Microtox) is a standardised aquatic toxicity test based on the marine bacterium A. 
fischeri (also known as Photobacterium fischeri and Vibrio fischeri). The photo-
luminescent bacteria are exposed to a chemical at different concentrations with the 
reduction of light emitted being regarded as the effect. The results from the Microtox 
assay include the concentration of a compound where light intensity is reduced by 50% 
(EC50). The pT value is the negative logarithm of the EC50, for the purposes of this 
chapter the units are in mmol L-1, and the measurement has historically been taken at 
different exposure times (5, 15 and 30 minutes) (Kaiser and Palabrica, 1991). As the A. 
Methods for assigning confidence to toxicity data with multiple values 
23 
 
fischeri toxicity assay is a well-standardised study, little experimental variability is 
assumed. However, there are some data, which can be regarded as low quality, which 
may be attributed to inter-laboratory variation and experimental error. Cronin and Schultz 
(1997) furthermore suggested that there is no significant influence of exposure times (5, 
15 and 30 minutes) on the toxicity of compounds, which act by non-polar narcosis. In this 
study non-polar narcosis is taken to be a non-specific mechanism of acute toxicity 
brought about by membrane perturbation (van Wezel and Opperhuizen, 1995; Ellison et 
al., 2008). As such, in aquatic toxicology, it is well established that the logarithm of the 
octanol-water partition coefficient (log P) is strongly related to the toxic potency of such 
compounds (Verhaar et al., 1992; Cronin et al., 1998; Zhao et al., 1998). 
The aim of this investigation was to develop methods and criteria to quantify the 
reliability of toxicity data when multiple values from different experimental 
determinations are available for the same chemical. To achieve this, historical literature 
data, measured in the A. fischeri assay were used. The effect of data quality was assessed 
by analysing log P-based QSARs for non-polar narcosis. Specifically, this involved: 
updating the Microtox data compilation of Kaiser and Palabrica (1991); identifying the 
non-polar narcotics within those data; developing statistical criteria for determining data 
reliability and; the development of log P-based QSARs for non-polar narcosis with 
different levels of quality / confidence score. 
 
2.2. Methods 
2.2.1. Toxicity data 
A literature search was conducted to obtain a large A. fischeri toxicity dataset (refer to 
Appendix A.1). The toxicity data of the compilation published by Kaiser and Palabrica 
(1991), consisting of 1350 A. fischeri EC50 entries, were supplemented with more 
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recently published A. fischeri assay data. Subsequently salts, mixtures, polymers, 
organometals and duplicates (data from the same study) were removed from the dataset. 
In the literature where different values for different exposure times were given, the result 
for the longest exposure time within the interval of 30 min ≥ t ≥ 5 min) was taken. 
Toxicity data corresponding to shorter or longer exposure times (t < 5 min; t > 30 min) 
were not considered. All EC50 values were converted to the negative logarithm of the 
EC50 in mmol L
-1. In common with the original terminology of Kaiser and Palabrica 
(1991), this was termed “pT”.  
 
2.2.2. Chemical structures 
Simplified Molecular Input Line Entry Specification (SMILES) strings for all compounds 
from the A. fischeri toxicity dataset were retrieved from the ChemSpider and 
ChemIDplus online chemical databases. Furthermore InChIKeys were created with the 
OpenBabel software (OpenBabel, 2013) using SMILES strings as input to identify 
identical compounds. Subsequently the dataset was cleaned, i.e. salts, polymers, 
inorganics and redundant data (data already identified in other literature) were omitted 
from the dataset, so that only organic compounds with at least one unique toxicity value 
per compound remained. 
 
2.2.3. Assignment to mechanism of action for acute aquatic toxicity 
To obtain information about the mechanism of action, the SMILES strings of the toxicity 
data were entered into the Toxtree software v2.5.0 (IDEAconsult, 2013). Toxtree holds a 
variety of toxicologically relevant decision trees used either for classification of 
chemicals or the elucidation of potential MoAs. The main purpose of the software is the 
classification of chemicals in the area of human and aquatic toxicology (IDEAconsult, 
2014a). In this context the modified Verhaar algorithm (Verhaar et al., 1992; Verhaar et 
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al., 2000; Enoch et al., 2008) was applied to identify compounds acting as non-polar 
narcotics (Class 1). These compounds were subsequently extracted from the A. fischeri 
dataset.  
 
2.2.4. Exposure times 
The influence of exposure times (5, 15 and 30 minutes) on the toxicity value obtained 
was compared for the compounds identified as acting by non-polar narcosis. According to 
Cronin and Schultz (1997), there was little or no influence of exposure time on the 
toxicity value, such that it is justified to merge A. fischeri toxicity data from 5, 15 and 30 
minute time points. To verify this, triplets of data, i.e. A. fischeri toxicity values for each 
compound at 5, 15 and 30 minutes were identified and compared via linear regression 
(refer to Appendix A.1).  
 
2.2.5. Calculation of physico-chemical properties 
Calculated log P values were obtained from KOWWIN v.1.68 from the freely available 
EPI Suite 4.11 (EPA, 2013) software. Molecular weights were calculated from the MOE 
2011.10 software (MOE, 2013). 
 
2.2.6. QSAR analysis 
The relationships between pT and log P for non-polar narcotics were examined using 
linear regression analysis in Minitab (Minitab, 2013). The data were plotted and a linear 
equation including n (number of data points), S (standard error), R2adj (coefficient of 
determination, adjusted for the number of degrees of freedom) and F and t statistics were 
generated (Livingstone, 2004). 
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2.2.7. Statistical analysis of toxicity data 
2.2.7.1.Omission of toxicity data outliers 
If the total number of different EC50 values for one compound was greater than five 
(n > 5), and single entries were outside of the range of ±50% of the median, then 
these so-called “data outliers” were omitted from the dataset. A truncated mean was 
calculated from the remaining EC50 values and the hence pT value was re-calculated 
(as shown in Figure 2.3). If n ≤ 5 for one compound, the arithmetic mean of all EC50 
values was used to calculate the final pT value for a compound. As a result, there is a 
single pT value per compound which was used for QSAR modelling. 
 
2.2.7.2.Confidence scoring 
A confidence score (CS) was assigned to the pT value for each compound. A 
compound with a single entry (n = 1) was assigned a confidence score of one (CS = 1). 
For n > 1 the confidence scores were calculated from the number of entries per 
compound (n) divided by the relative standard deviation (RSD), where RSD is the 
ratio of the standard deviation (SD) and arithmetic mean (x̅): 
 𝑅𝑆𝐷 =
𝑆𝐷
?̅?
            (Eq. 2.1) 
   𝐶𝑆 =
𝑛
𝑅𝑆𝐷
             (Eq. 2.2) 
For the toxicity data, two confidence score (CS) thresholds were investigated here, i.e. 
where CS(1) > 5 and CS(2) > 15 respectively. 
 
2.3. Results 
The outcome of the retrieval and the cleaning of the A. fischeri toxicity data and 
subsequent identification of non-polar narcotics are described below. Furthermore, 
analysis of toxicity values with respect to exposure time, to investigate the significance of 
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the duration of the assay, as well as the analysis with respect to data quality from 
statistical assessment, is reported. 
 
2.3.1. Retrieval and cleaning of A. fischeri toxicity data 
A literature review revealed many sources of toxicity data from the A. fischeri assay. 
These supplemented the compilation of Kaiser and Palabrica (1991), which provided 
references to 28 papers and approximately 1350 data. A further 600 data were obtained 
giving a total of 1944 A. fischeri toxicity entries for over 1300 compounds. After cleaning 
the data to remove toxicity values for ambiguous structures, salts, polymers etc. a total of 
1813 entries for 1227 compounds were obtained. This complete dataset is available as an 
Excel table in Appendix A.1. 
 
2.3.2. Identification of non-polar narcotics 
Of the cleaned 1813 A. fischeri toxicity data for the 1227 different chemical compounds, 
203 of these compounds were identified as having a very strong probability of acting by 
the non-polar narcosis mechanisms of action. The initial assignment was performed using 
the modified Verhaar rules, which provide a robust starting point (Verhaar et al., 1992; 
IDEAConsult, 2013). It is appreciated that this may be a conservative approach and that 
more compounds in the dataset may fall within the non-polar narcosis domain, however, 
the Verhaar rules were utilised to provide a defensible and repeatable method for the 
selection of non-polar narcotics. 
 
2.3.3. Analysis of A. fischeri toxicity data with respect to exposure time 
For the purposes of considering data quality it would be highly beneficial to be able to 
combine data from the different time points. In order to assess the feasibility of this, 99 of 
the non-polar narcotic triplets, i.e. compounds identified as being non-polar narcotic, with 
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data for all three exposure times, were considered. Figure 2.2 and Equations 2.3 to 2.5 
show the relationships between toxicity data from all three time points. There are no 
significant differences between the toxicity data as illustrated by an intercept approaching 
zero and a slope of unity for the regression equations between the exposure times. As a 
result of this analysis, confirming insignificant differences between the toxicity data for 
different exposure times, the data for different time points were combined, with the 
longest exposure being used by preference: 
pT(30min) = - 0.04 + 0.97 pT(5min)           (Eq. 2.3) 
   n = 99, R2adj = 0.99, S = 0.14, t = 90.0, F = 8020 
 
pT(15min) = - 0.02 + 0.99 pT(5min)           (Eq. 2.4) 
   n = 99, R2adj = 1.00, S = 0.09, t = 133, F = 17700 
 
pT(30min) = - 0.02 + 0.98 pT(15min)          (Eq. 2.5) 
   n = 99, R2adj = 1.00, S = 0.08, t = 154, F = 23600 
 
 
Figure 2.2: Comparison of the effect of exposure times (5, 15 and 30 min) of the pT values for 99 
non-polar narcotics (refer to Appendix A.1) 
 
2.3.4. Analysis of A. fischeri toxicity data with respect to data quality 
Many compounds had more than a single toxicity value. In order to investigate the 
concept of data reliability and quality, the (truncated) mean was calculated for these 
compounds. Taking methanol as an example, toxicity test data are available from ten 
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separate publications. The full set of test results and data are shown in Figure 2.3. 
Consideration of all ten data points gives a mean of 8.61 x 104 ppm and SD of 8.45 x 104 
ppm. When data outliers were omitted, with a tolerance of ± 50% of the median (Min, 
Max), this resulted in only six mid-range entries with a mean of 5.02 x 104 ppm and SD 
of 1.61 x 104 ppm remaining for methanol (refer to Figure 3). As a consequence of the 
removal of the “data outliers” there is a predictable reduction in (relative) standard 
deviation and increase in the confidence score (CS). The ID numbers in Figure 3 are 
identifiers used during the data collection (refer to Appendix A.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       Figure 2.3: Microtox toxicity data for methanol and analysis to identify 
       “data outliers” and calculate the confidence score 
 
 
2.3.5. Investigation of the effect of data quality on QSARs 
The same principle of data outlier omission and confidence scoring, as undertaken for 
methanol, was applied to the whole A. fischeri dataset. Therefore, for compounds with 
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more than five data points (n > 5), truncated means with a reduced influence of outliers 
and higher confidence scores (CS) were created where such outliers were identified.  
Figure 2.4 shows the relationship of toxicity and log P for non-polar narcotics, where the 
effect of data outlier omission and confidence scoring, have been applied: In the left 
column (Figure 2.4A, 2.4C and 2.4E) no data outlier omission was applied and in the 
right column (Figure 2.4B, 2.4D and 2.4F) data outlier omission was applied. In first row 
(Figure 2.4A and 2.4B) no confidence score threshold was applied, in the second row 
(Figure 2.4C and 2.4D) a confidence score threshold of CS(1) > 5 was applied and in the 
third row (Figure 2.4E and 2.4F) a confidence score threshold of CS(2) > 15 was applied. 
The linear correlations between pT and log P in the first row of Figure 2.4A and 2.4B are 
weak (R2adj of 0.50 and 0.51 respectively). The confidence score thresholds for the second 
and the third row (C, D and E, F) allowed only “high quality” data to be plotted. Figures 
2.4C and 2.4D (CS(1) > 5) and Figures 4E and 4F (CS(2) > 15) show stronger linear 
correlations (R2adj > 0.79) than Figures 2.4A and 2.4B. As the confidence score threshold 
of CS(2) is stricter than CS(1), the second row (Figure 2.4C and 2.4D) contains more 
compounds (n = 40 and n = 43 respectively) than the third row (Figure 2.4E and 2.4F) 
with n = 12 and n = 17 respectively. Overall the following six QSAR equations (2.6 to 
2.11), referring to Figure 2.4A to 2.4F, were developed: 
 
 A:   pT = 0.68 log P - 1.14                      (Eq. 2.6) 
n = 203, R2adj = 0.50, S = 0.95, t = 14.3, F = 204.0 
 
 B:   pT = 0.68 log P - 1.11                      (Eq. 2.7) 
n = 203, R2adj = 0.51, S = 0.93, t = 14.5, F = 211.0 
   
 C:   pT = 1.08 log P - 2.21                      (Eq. 2.8) 
n = 40, R2adj = 0.81, S = 0.65, t = 13.0, F = 168.0 
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 D:   pT = 1.08 log P - 2.20                 (Eq. 2.9) 
n = 43, R2adj = 0.81, S = 0.63, t = 13.6, F = 185.0 
 
E:   pT = 1.12 log P - 1.92                (Eq. 2.10) 
n = 12, R2adj = 0.79, S = 0.80, t = 6.5, F = 42.8 
 
 F:   pT = 1.23 log P - 2.31                (Eq. 2.11) 
n = 17, R2adj = 0.83, S = 0.75, t = 9.0, F = 81.3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Relationship between A. fischeri toxicity (pT) and log P: Figure 2.4A containing pT 
arithmetic means (n = 203); Figure 2.4B containing pT arithmetic means after an median-based 
data outlier omission (n = 203); Figure 2.4C containing pT arithmetic means with a confidence 
filter (CS(1) > 5; n = 40), Figure 2.4D containing pT arithmetic means with a confidence filter 
(CS(1) > 5; n = 43) after an median-based data outlier omission; Figure 2.4E containing pT 
arithmetic means with a confidence filter (CS(2) > 15; n = 12); Figure 2.4F containing pT 
arithmetic means with a confidence filter (CS(2) > 15; n = 17) after median-based data outlier 
omission 
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2.4. Discussion 
There is an increasing availability of toxicity data from various relatively standardised 
assays, which have been brought together in REACH submissions, the OECD QSAR 
Toolbox, eChemPortal and a variety of other freely available and accessible resources etc. 
An often asked question is which value is representative when multiple data points are 
available for the same compound from the same test. This analysis has provided a means 
to evaluate multiple data entries and thus, in part at least, begins to answer that question 
as well as supporting regulatory decisions and the creation of robust datasets for model 
building and read-across. The A. fischeri assay is a well-standardised technique; it is 
essentially a simplistic cytotoxicity assay, meaning variability of measurements within 
and between laboratories should be low. Within the compiled dataset, the non-polar 
narcosis-associated toxicity data from the A. fischeri assay were chosen due to the 
number of available data. 
For compounds with multiple toxicity data points, statistical analysis was undertaken 
(refer to Figure 2.3). The purpose of this was to identify, and hence remove, data outliers. 
These outliers were selected on an empirical and statistical basis. It was not possible to 
determine if there were experimental anomalies as the original “study reports” were not 
available, as is common for online databases of toxicity values. Figure 2.3 illustrates this 
concept; the approach of removing statistical outliers is transparent and clear. It provides 
a useful analysis of the data, especially when combined with the confidence score (CS) 
discussed below. In this analysis an arbitrary cut-off of 50% of SD was applied. This was 
identified following a process of trial and error (results not shown in this analysis) but 
could be adapted e.g. if more or less variability was considered acceptable for a test.  
The relationship between toxicity (pT) and lipophilicity (log P) for non-polar narcotics is 
shown in Figure 2.4. The resulting QSAR equations are not significantly different from 
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those published previously (Cronin and Schultz, 1997; Vighi et al., 2009). When no data 
restrictions are selected (Figures 2.4A and 2.4B) the resultant QSARs are less precise in 
terms of statistical fit and robustness as compared to those developed using certain data 
selections (from Figure 2.4C, 2.4D, 2.4E and 2.4F). Therefore an assessment and 
quantification of data quality will assist in the development of more robust QSARs and 
computational models. To select the data in an objective manner, arbitrary confidence 
scores (CS(1) > 5 and CS(2) > 15) were taken as thresholds. Principally, the higher the 
CS the more evidence, in terms of similar results for one compound is available, i.e. the 
result is regarded as more trustworthy than a compound with a low CS. Even with low 
numbers of data (n) and high relative standard deviation (RSD), it is impossible for CS to 
fall below one (CS < 1). Usually CS = 1 means that there is only one data point per 
compound. This can be regarded as the lowest (statistical) confidence that can be attached 
to a datum point. At this point it must be stressed that confidence does not necessarily 
relate to reliability. For many compounds the results of a single toxicity test may be 
highly reliable, it is simply that there is lower confidence as the value has not been 
replicated. As such, the plots in Figure 4C to 4F show a smaller number of data points (n 
= 40, 43, 12 and 17 respectively) due to a filtration process based on confidence scoring. 
In Figures 2.4C and 2.4E only data with high confidence scores (CS > 5 and > 15 
respectively) were considered. Both show the strong linear relationship that is 
fundamental to non-polar narcosis (Ellison et al., 2008). The inclusion of data with the 
lower confidence threshold (refer to Figure 2.4D) allows more data points (compounds) 
to be considered in the QSAR.  
The data outlier omission on its own leads to more centralised (closer to the median) 
values, it also reduces the variability/spread of an associated dataset and so increases the 
corresponding CS value. This leads to more confidence being associated with the data 
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points in Figures 2.4D and 2.4F compared to Figures 2.4C and 2.4E respectively. It is 
open for discussion which of Figures 2.4D (equation 2.9) or 2.4F (equation 2.11) is the 
better model for non-polar narcosis: on the one hand Figure 4F has a better statistical fit 
( R2adj = 0.83), in contrast Figure 2.4D incorporates more contributing data points. 
The effect of the data outlier omission between Figures 2.4A and 2.4B is only marginal 
(R2adj 0.50 and 0.51 respectively). Both Figures contain 203 data points, but in Figure 
2.4B fewer data points are orientated towards the line of best fit than in Figure 2.4A, 
based on the stabilising effects of the data outlier omission and truncated mean 
respectively. The effect is negligible as most compounds have only one data point, i.e. 
one single EC50 entry. The strength of the QSARs reported in Figures 2.4D and 2.4F is 
that data outlier omission incorporates more data points (than Figures 2.4C and 2.4E). 
The greater the number of data points contributing to a correlation or QSAR, the greater 
the weight of evidence for a correlation and QSAR respectively. This confirms that data 
outlier omission is a useful tool, particularly in combination with CS thresholds. 
The confidence scoring, particularly when combined with the median-based data outlier 
omission, is a mathematical method to assess reliability of toxicity data where there are 
multiple entries for a single value. The metric confidence scores provided by this method 
can be used as thresholds or as pre-factors for weighting as described by Przybylak et al. 
(2012) or Yang et al. (2013). The statistical tools used, i.e. data outlier omission and 
confidence scoring, show an improvement of the model by defining “reproduced” 
(multiple and similar) data to be more reliable than single or non-reproducible data. 
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Figure 2.5: Detailed examination of Figures 2.4C and 2.4D showing compounds with excess     
toxicity 
 
 
The investigation of Figures 2.4C and 2.4D (refer to Figure 2.5) revealed three data 
points with a high pT to log P ratio, indicating excess toxicity above non-polar narcosis.  
 
 
 
 
 
Figure 2.6: Chemical structures of aflatoxin B1 (A), acetylacetone (B) 
and pentachloroethane (C) 
 
These three compounds are aflatoxin B1, acetylacetone and pentachloroethane which are 
known to have toxicity-related modes of action other than non-polar narcosis (refer to Fig. 
2.6). Aflatoxins are well known for their mutagenic, teratogenic, carcinogenic and in 
higher doses hepatotoxic effects. Typically aflatoxin is activated by enzymes of the 
cytochrome P450 family to an epoxide, which reacts with macromolecules including 
DNA, RNA and proteins. This mechanism is relevant not only for cancer and liver 
disease but also for direct cytotoxic effects (Wehner et al., 1978; McLean an Dutton, 
1995; Frisvad et al., 2006). In 2004, acetylacetone (pentane-2,4-dione) was identified as 
genotoxic and subsequently banned by the EC as a food additive (EC, 2005). According 
to the mechanistic studies of Enoch et al. (2011) it is likely to act as a Schiff base and 
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protein binder. Pentachloroethane on the other hand showed no protein binding potential 
or any other related toxicity according to Enoch et al. (2011) but nevertheless most safety 
sheets label this substance as toxic. Pentachloroethane and hexachloroethane 
administered orally showed adverse effects, such as renal inflammation, hepatocellular 
carcinoma and increased lethality, in rats (Mennear et al., 1982). Classifying these 
compounds as non-polar narcotics (Class 1) might not be an adequate decision by the 
Toxtree software and this provides some indication as to how to improve/modify the 
Verhaar rules in the Toxtree software. The excess toxicity, compared to the non-polar 
narcosis-associated toxicity, could be explained by these mechanisms (Lipnick et al., 
1987). 
 
2.5. Conclusions 
A transparent method to identify reliable toxicity data and values for modelling, as well 
as providing confidence for the use of multiple entries has been developed. This will 
assist in the harvesting of reliable toxicity values from what may be considered as 
variable quality data. The ability to assess conflicting toxicity data is important not only 
for developing models in computational toxicology, but also for the use of the increasing 
number of toxicity databases available. It should be remembered that even toxicity data 
with a low confidence score may be highly reliable (as a single, measured data point can 
be accurate per se), however the approaches proposed in this study will be beneficial to 
analysing some of the larger datasets that are increasingly becoming available. The 
analysis confirms that data with higher confidence, as defined in this study, produce more 
robust QSARs. 
The results from Chapter 2 show that a novel method to assess data quality from a 
statistical perspective has been developed (and published as Steinmetz et al. 2014). This 
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provides a means to evaluate the information from the increasing number of databases 
with multiple data for the same compound. This study has been extended in Chapter 3 by 
the use of CS-weighted regression to build QSAR models. Additionally a second dataset 
with high relevance to the assessment of cosmetic ingredients, i.e. a compilation of skin 
permeability coefficient data, has been investigated. 
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3. Using statistical confidence scoring to improve QSAR/QSPR 
modelling* 
3.1. Introduction 
As already explained in detail in Chapter 2, the assessment of biological/toxicological, 
data quality is crucial for many disciplines, e.g. QSARs, grouping and read-across 
(Nendza et al., 2010; Przybylak et al., 2012; Péry et al., 2013). There are two general 
approaches to assess the quality of biological/toxicological data; based on the assessment 
of the reported testing information (GLP etc.) and based on statistical data quality (CS 
etc.) if multiple and comparable data are available (Steinmetz et al., 2014). 
As the assignment of CS values to toxicological data is not a common method to date, 
some theoretical examples are given to facilitate interpretation. Examples of calculations 
of CS values are provided in Table 3.1, illustratively representing scenarios of increasing 
CS values. Compound A is the default scenario (the most common occurrence whereby a 
compound has only a single experimental value), the CS is 1. Compound B has two 
relatively divergent data values, differing by an order of magnitude. Clearly there will be 
greater confidence for the toxicity value than for compound A, but the significant 
difference in the values introduces some uncertainty, raising CS marginally to 1.73 – in 
this way there is slightly greater confidence associated with two relatively different 
values than a single value. More data points are considered for compounds C and D, with 
increasing precision of the data values. Whilst compound C (n = 4) has more data than 
compound D (n = 3), the values are more divergent for C (represented by a higher RSD), 
thus the highest CS is calculated for compound D for which there are three data points, all 
relatively consistent in the light of the experimental error that might be associated with an 
experimental test. As such, compound D has the highest CS value. 
*This chapter is based on a published article (Steinmetz et al., 2015b) 
Using statistical confidence scoring to improve QSAR/QSPR modelling 
 
39 
 
Table 3.1: Four examples of compounds with multiple data in the same toxicity test (EC50), along 
with statistical criteria and CS (refer to Appendix A.2) 
Compound EC50 (mol/L) x̅ ± SDa RSDb nc CSd 
A 10 10 ± n/a n/a 1 1e 
B 
1 
5.50 ± 6.36 1.16 2 1.73 
10 
C 
1 
57.75 ± 43.05 0.75 4 5.37 
80 
50 
100 
D 
1 
1.47 ± 0.50 0.34 3 8.74 2 
1.4 
amean and standard deviation  
brelative standard deviation  
cnumber of data 
dconfidence score  
eCS of a compound with n = 1 is defined as 1 is the minimum value 
 
As there is growing interest in techniques such as read-across to fill data gaps for 
regulatory purposes, and there is increasing accessibility to toxicity data through 
resources such as the OECD QSAR Toolbox to perform read-across, there are more 
possibilities to apply approaches such as the confidence scoring to improve the 
robustness of modelling. In this study the relevance of the CS approach has been assessed 
with regard to established QSARs for two endpoints, namely skin permeability 
coefficients and cytotoxicity for which large compilations of historical data are available. 
 
 
 
Using statistical confidence scoring to improve QSAR/QSPR modelling 
 
40 
 
3.1.1. Skin permeability 
There have been many efforts to develop Quantitative Structure-Permeability 
Relationship (QSPR) models to predict various measures of dermal absorption 
(Scheuplein and Blank, 1971; Potts and Guy; 1992; Abraham et al., 1997; Magnusson et 
al., 2004; Dancik et al., 2013; Khajeha and Modarress, 2014). The most recognised and 
applied QSPR to predict the skin permeability coefficient (kp) is that developed by Potts 
and Guy in 1992 (Eq. 3.1). They used the molecular weight (MW), to account for the size 
of a permeant and log P, as a descriptor for lipophilicity, as parameters to model kp 
following an analysis based on the Flynn data compilation (Flynn, 1990). The 
mechanistic explanation is that small, lipophilic compounds pass through the stratum 
corneum, the outermost layer of the skin, more easily than larger, more hydrophilic 
compounds. As shown in Figure 3.1, the transport termed diffusion occurs within the 
lipophilic phase between keratinocytes (Potts and Guy, 1992; Mitragotri et al., 2011). 
 
log kp (cm/h) = -2.7 + 0.71 log P - 0.0061 MW          (Eq. 3.1) 
 
Figure 3.1: Diagrammatic representation of the skin showing the inter- 
cellular transport of xenobiotics through the stratum corneum (black arrow) 
 
Despite the significance of Eq. 3.1, the quality of data compiled from the literature by 
Flynn, and hence the robustness of the Potts and Guy QSPR, has been the subject of 
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considerable debate (Moss and Cronin, 2002; Johnson et al., 1995). More human in vitro 
kp data have inevitably become available in the two and half decades since Flynn’s 
seminal publication (Moss and Cronin, 2002; Chauhan and Shakya, 2010; Chen et al., 
2013; ten Berge, 2014), thus the QSPR can be reassessed and rebuilt with a greater 
consideration and understanding of data quality.  
 
3.1.2. Aquatic toxicology 
As described more in detail in Chapter 2, there is a myriad of publically available eco-
toxicological data, accessible for example via EPA’s ECOTOX database (EPA, 2015b). 
The multitude of published A. fischeri data (as compiled in Steinmetz et al. (2014) and 
Chapter 2 respectively) was used within this study.   
These two examples are illustrative of the possibilities of applying confidence scoring 
metrics to historical compilations of toxicity information. There are many open-access 
resources such as ChEMBL (2015), PDSP (2015), ACToR (EPA, 2015a), eChemPortal 
(OECD, 2015), TOXNET (NIH, 2015), so the life sciences, and in particular toxicology, 
has to deal increasingly with large and complex datasets (Zhu et al., 2014). However, the 
task of assessing the toxicity data for quality, particularly when contradicting data are 
present, has not yet been accomplished. Any indication of the quality of data would be 
very helpful for purposes such as risk assessment, but more crucially for modelling 
including QSARs and read-across prediction (Przybylak et al., 2012; Steinmetz et al., 
2014).  
Therefore, the aim of this study was to investigate how using approaches for statistical 
data quality, i.e. CS, improves the development of QSAR/QSPR models. Specifically, the 
effect of directly incorporating the CS into the training and testing of the models was 
considered. To achieve this, the two endpoints described above were chosen for analysis, 
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namely human in vitro skin permeability coefficients and the acute toxicity of compounds 
acting by a non-polar narcotic mechanism of action to A. fischeri. The reasons for 
choosing these endpoints included the fact that there were many historical data of 
variable and unknown quality, many compounds had been tested multiple times (a pre-
requisite of applying the CS) and that there were simple, robust and mechanistically 
interpretable QSAR models for them. Thus, for both datasets, QSARs were constructed 
with and without reference to the CS.  
 
3.2. Methods 
3.2.1. Data harvest 
In vitro skin permeability coefficients (kp) were collected from the literature by compiling 
and subsequently merging four of the most comprehensive datasets of human skin kp 
values (Moss and Cronin, 2002; Chauhan and Shakya, 2010; Chen et al., 2013; ten Berge, 
2014). All kp values were converted to a standard unit (cm/h). Duplicate log kp values 
(and those within ± 0.01 cm/h) were removed as they are most likely to be derived from 
the same source. SMILES and InChIKey strings were obtained for each compound from 
the ChemSpider website (RSC, 2014). The Flynn (1990) dataset contained kp values for 
94 compounds, however, 11 compounds (all substituted steroids) could not be identified 
by ChemSpider (RSC, 2014) or ChemIDplus (US NIH, 2014) and hence no SMILES 
were available to calculate descriptors. Since the structure of these compounds could not 
be completely verified they were excluded from subsequent analysis. 
The A. fischeri data compilation from Chapter 2 (Steinmetz et al., 2014) was used as the 
resource for the aquatic toxicology dataset. The chemical structures (as SMILES strings) 
of the comprised 1227 compounds were run through IDEAconsult’s Toxtree v2.6.6 
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(modified Verhaar) and non-polar narcotics were identified as being Class 1 according to 
the Verhaar scheme (Verhaar et al., 1992; IDEAconsult, 2014a). 
 
3.2.2. Descriptor generation 
Log P and molecular weight (MW) were calculated for compounds in both datasets. The 
SMILES strings were used as the input format for all calculations. Log P was calculated 
with KOWWIN v1.68 within EPI Suite 4.11 (estimated values exclusively) (EPA, 2014). 
MW was calculated with the CDK node “molecular properties” within KNIME 2.9 
(KNIME, 2014). 
 
3.2.3. Calculation of confidence score (CS) 
Confidence scores were calculated for the compounds in both datasets with regard to their 
kp and EC50 values respectively. For compounds with more than a single experimental 
value, the arithmetic mean (x̅), number of data points (n), SD and RSD were calculated 
with reference to data in the units stated in Section 3.2.1 and before logarithmic 
transformation. A CS was assigned to the arithmetic mean of the experimental values for 
each compound. Compounds with a single entry (n = 1) were assigned a confidence score 
of one (CS = 1). For compounds with n > 1, the CS was calculated as in Eq. 2.2. 
 
3.2.4. Development of QSARs/QSPRs 
Uni- and multivariate linear regression was performed on the datasets using R Studio 
0.98.501.19 (R, 2014). Linear equations were generated and the following statistical, and 
other, criteria recorded: n (number of data points), S (standard error), R2adj (coefficient of 
determination, adjusted for the number of degrees of freedom), t statistics for the 
descriptors and F statistics for the equation. Regression analysis was performed to 
develop the QSARs for both datasets with and without weighting. Non-weighted 
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regression analysis and weighted regression analysis was performed by applying CS 
values as weights in R using the default package lm {stats}. Weighting in linear 
regression means that each datum point is associated with a weight. A high weight 
strengthens, and a low value weakens, the impact of the data point towards the linear 
regression. In this manner, data for compounds associated with a high confidence score 
would be more heavily weighted in the regression analysis than compounds with a lower 
confidence score. Comparison of the statistics of the weighted and unweighted regression 
analysis provides an indication of whether CS is able to improve the robustness of 
models.    
 
3.2.5. Evaluation of the predictivity of the QSARs/QSPRs 
Statistical evaluation of the predictive capability of the CS-weighted QSAR and the CS-
weighted QSPR was performed using 10-fold cross-validation, i.e. the compounds were 
ordered by kp and pT respectively and every 10
th compound was removed in turn leading 
to 10 training and validation sets. After applying the CS-weighted linear regression, the 
10 datasets were investigated by the root mean square error (RMSE); predicted (fi) versus 
experimental (yi) values. Additionally the root mean square error adjusted for CS 
(RMSECS) was calculated (Eq. 3.2). It is expected that during the validation process, the 
RMSECS, which incorporates CS-weighting, will be lower than the standard RMSE. As 
the residuals (fi - yi) of the compounds with low CS values are weakened and the 
residuals of high CS compounds are strengthened, the sum of (squared) errors of the 
RMSECS should be reduced in comparison to the conventional RMSE. The R script for 
RMSECS cross-validation and the equations are available in Appendix C.2. 
RMSECS =  √
∑ CSi(fi−yi)
2
i
∑ CSii
        (Eq. 3.2) 
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3.3. Results 
Names of compounds, their InChIKeys and SMILES strings along with all kp and pT 
values including references are available for the two datasets in Appendix A.2. 
Furthermore a glossary of relevant statistical equations is attached. In addition the R 
script for RMSECS cross-validation is available in Appendix C.2. 
 
3.3.1. Data harvest 
The compilation of human in vitro kp data resulted in 342 values for 226 different 
compounds. 55 of these compounds have more than a single kp value. The log kp values 
covered a broad range from -6.10 to 0.16. The structures included in the dataset were 
diverse in terms of physico-chemical properties and structure, e.g. solvents, alkaloids, 
steroids, sugars, nonsteroidal anti-inflammatory drugs etc. The solvents, sugars and 
steroids in particular, had many multiple data points. Water, with 13 different data points, 
had the most kp values. The range of CS values is from 1 (for single entries) to 76.8 for 
chlorphenamine (based on two data points). Illustrating the capability of the CS approach, 
two compounds have moderately high CS values: the synthetic opioid sufentanyl with a 
CS value of 9.97 (based on two data points) and the cytostatic drug 5-fluorouracil with a 
CS value of 5.00 (based on four data points). 
From the complete dataset of acute toxicity values to A. fischeri, comprising 1227 
compounds, 203 were identified as potentially acting as non-polar narcotics according to 
the Verhaar scheme as implemented in Toxtree v2.6.6 (IDEAconsult, 2014a).  A total of 
418 different pT values were available for these compounds, with 71 of the 203 
compounds having more than a single experimental value. pT values covered a broad 
range from -4.00 to 4.12. The structures included in the dataset were conservative in their 
structural diversity as they had been selected to represent the non-polar narcosis domain, 
including mainly solvents and medium- and long-chained alkanes, partly branched and 
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halogenated, with only a few functional groups, such as hydroxyl- and amino-groups. The 
compounds investigated have a moderate spread of MW and log P and can generally be 
regarded as lipophilic (refer to Table 3.2). The CS spread shows the diversity between 
high confidence compounds, such as methyl isobutyl ketone (CS of 205 with 3 data 
points) and acetone (CS of 43.7 with 14 entries) and the single entry low confidence 
compounds (defined as CS = 1). 
 
Table 3.2: Ranges of properties and CS for the two datasets considered in the analysis 
 Human in vitro skin permeability coefficients pT of non-polar narcotics to A. fischeri 
MW (Da) 18.01 to 764.44 32.04 to 342.43 
Log P -6.76 to 8.39 -1.34 to 6.43 
CS 1 to 76.8 1 to 205 
 
 
3.3.2. Development of QSARs/QSPRs 
QSAR/QSPR models were developed using linear regression with the experimental log kp 
and pT as the dependent variables and log P and MW (for kp only) as descriptors. Linear 
regression analysis was performed on both datasets, the resultant QSPRs for skin 
permeability coefficients based on the Potts and Guy approach (Eq. 3.3 (unweighted), Eq. 
3.4 (weighted), Fig. 3.2) and the log P-based QSARs for the acute toxicity of non-polar 
narcotics to A. fischeri (Eq. 3.5 (unweighted), Eq. 3.6 (weighted), Fig. 3.3) are reported 
below. 
 
3.3.2.1.QSPR: Modelling of the skin permeability coefficient 
The unweighted QSPR for the dataset of skin permeability coefficients, using the 
Potts and Guy approach, was: 
      log kp = -2.45 + 0.40 log P - 0.0045 MW           (Eq. 3.3) 
 n = 226, R2adj = 0.48, S = 0.82, tlogP = 13.3, tMW = -8.97, F = 105 
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The reanalysis using CS-weighted kp provided the following, similar, equation with 
improved statistical fit: 
     log kp = -2.51 + 0.50 log P - 0.0051 MW           (Eq. 3.4) 
n = 226, R2adj = 0.61, S = 1.39, tlogP = 18.7, tMW = -9.25, F = 177 
Experimental kp values are plotted against predicted values from Eq. 3.4 in Figure 3.2, 
demonstrating good overall predictivity. In particular, there is a good fit about the line 
of unity, with a significant trend for compounds with the highest CS (represented by 
larger circles) to be well predicted, and the significant outliers tending to be 
compounds with low CS, i.e. single data points.  
 
Figure 3.2: Experimental log kp versus predicted log kp from Eq. 3.4; the 
area of circles corresponding to the CS value; the larger the CS, the greater 
the area of the circle; the solid line indicating a slope of unity and an intercept 
of zero 
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The QSPR model represented by Eq. 3.4 was tested using 10-fold cross-validation. The 
statistical summary is presented in Table 3.3. Notably the RMSECS is lower than the 
RMSE. 
 
  Table 3.3: Statistical summary of 10-fold cross-validation based on Eq. 3.4 (skin permeability) 
Training  Test 
Intercept  Log P   MW  R2adj  RMSE RMSECS 
 -2.51 
± 0.09 
 0.497 
± 0.026 
-0.0051 
± 0.0004 
 0.61 
± 0.02 
 
 0.83 
± 0.21 
 0.79 
± 0.21 
 
 
3.3.2.2.QSAR: Modelling of A. fischeri non-polar narcosis 
The unweighted QSAR for the non-polar narcotics in the Microtox dataset, using a 
log P-based linear regression was: 
pT = -1.14 + 0.68 log P            (Eq. 3.5) 
n = 203, R2adj = 0.50, S = 0.95, tlogP = 14.3, F = 204 
The reanalysis using CS-weighted pT provided the following equation with improved 
statistical fit: 
pT = -1.67 + 0.92 log P            (Eq. 3.6) 
n = 203, R2adj = 0.68, S = 1.77, tlogP = 20.9, F = 478 
 
Figure 3.3 demonstrates the relative predictivity of Equation 3.6. There is a good fit 
about the line of unity, with a significant trend for compounds with the highest CS 
(represented by larger circles) to be well predicted, and the significant outliers tending 
to be compounds with low CS, i.e. single values (similar to kp modelling). 
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Figure 3.3: Measured pT versus predicted pT from Eq. 3.6; the area of 
circles corresponding to CS value; the larger the CS, the greater the area 
of the circle; the solid line indicating a slope of unity and an intercept of 
zero 
 
The QSAR model Eq. 3.6 was assessed with 10-fold cross-validation. The summary of 
the statistics for Eq. 3.6 is presented in Table 3.4. The RMSECS is lower than the 
RMSE. 
 
  Table 3.4: Statistical summary of 10-fold cross-validation based on Eq. 3.6 (aquatic toxicity) 
Training    Test  
Intercept  Log P  Radj2  RMSE RMSECS 
 -1.67 
± 0.14 
  0.92 
± 0.04 
 0.68 
± 0.03 
 
 0.99 
± 0.12 
 0.87 
± 0.13 
 
3.4. Discussion 
There are many future challenges in human and environmental health sciences which 
require the use of adequate and reliable data, these include toxicological risk assessment 
for occupational health and consumer goods. As the quality of toxicological data is 
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variable and often not stated, practical and feasible methods to overcome this issue are 
crucial to many scientific and regulatory fields. Beside approaches such as Klimisch 
scoring (Klimisch et al., 1997), a purely statistics-based method to support modelling 
approaches was proposed in Chapter 2 and expanded within this Chapter. It is difficult to 
determine the extent to which such a statistically-driven approach could be used for 
regulatory purposes, but neglecting the information multiple data hold for the same 
substance is not recommended if such data are available.  
The aim of this work was not to build new QSAR/QSPR models, but to make two 
existing models more robust using independent, heterogeneous datasets. The two QSARs 
and associated datasets chosen are well established. In this study the datasets have been 
extended by further data harvesting and collection. As part of the data collection activity, 
multiple data were compiled for the same chemical, thus allowing for the application of 
the CS approach to determine the reliability of the data. This approach has not been 
applied formally in the development of QSARs and there are no clear guidelines on how 
to develop QSARs when multiple data are available for the same chemicals (i.e. use of 
the mean, most conservative value etc.). In addition, there appear to be few, if any, 
attempts to include information such as data quality as a metric or criterion for QSAR 
development, this being despite it being logical and acknowledged that data quality will 
affect the robustness of a QSAR (Wenlock and Carlsson, 2015). It should also be noted 
that current means of documenting QSARs provide little opportunity for assessing the 
quality of data. Therefore approaches that allow us to identify data quality quantitatively 
and without subjective bias are of value in the development of in silico models.   
Skin permeability is often assessed by in vitro experimentation, but also some in vivo 
work is undertaken. In silico models are increasingly desirable in areas such as risk 
assessment where there is dermal exposure (e.g. for cosmetics) and for assessing adverse 
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effects to the skin, e.g. skin sensitisation. Since the publication of the Flynn dataset 
(1990), there have been a number of QSPR analyses of skin permeability coefficients 
including refinements and extensions to the database (Mitragotri et al., 2011). The Potts 
and Guy (1992) approach, based on fundamental and mechanistically comprehensible 
descriptors, is one of the more commonly utilised QSPR modelling methodologies. This 
study has derived a Potts and Guy equation for a larger dataset not only increasing the 
coverage of the model (i.e. greater chemical space) but also incorporating multiple data 
points for the same chemical and allowing for an assessment of quality through CS. It is 
noted that published skin permeability coefficients are highly variable, due in no small 
part to high experimental error arising from the variable nature of the (human) skin 
utilised and test protocols, e.g. use of solvents, enhancers, finite doses, vehicles, solvents 
etc. (Moss and Cronin, 2002; Johnson et al., 1995). As such, it is to be expected that 
models will not have a very significant statistical fit (i.e. a high R2) and this is borne out 
by many of the published models (Potts and Guy, 1992; Moss and Cronin, 2002), indeed 
models with significant fit should be treated with some caution as they may be overfitted.  
Whilst high statistical fit was not achieved for the skin permeability QSPRs, the results 
show a significant relationship between log kp and log P and MW with both variables 
having high t-values. The new QSPR has moderately improved statistical fit as compared 
to that of Potts and Guy (1992). It should be noted that some values within the Flynn 
dataset were subsequently shown to be incorrect and would have increased the error in 
the Potts and Guy QSPR (Johnson et al., 1995). The novel QSPR model (refer to Eq. 3.4 
and Fig. 3.2) derived from the skin permeability data has some advantages over the 
original Potts and Guy model. First of all increased robustness, due to model 
development incorporating statistical data quality (refer to Table 3.3); secondly a greater 
applicability domain due to implementing a dataset with greater chemical diversity (in 
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terms of properties and structure) than Flynn (1990); and thirdly due to the usage of 
calculated log P (whereas the original model used measured values which are more 
difficult to obtain consistently). Nevertheless the differences between Potts and Guy’s Eq. 
3.1 and Eq. 3.4 are only marginal. It is recognised that there are many limitations to this 
use of this model. For example it does not predict the effects of mixtures and 
formulations on the penetration of single compounds, which could be of great importance 
for risk assessment of products and dermal drug delivery (Samaras et al., 2012). 
However, the QSPR approach allows for a “relative” estimation of skin permeability 
which may be useful to rank compounds, or identify compounds with a high probability 
of dermal absorption and hence prioritise such compounds in the risk assessment process 
(e.g. for skin sensitisation).  
Non-polar narcosis in the context of the A. fischeri assay was discussed in Chapter 2 
(Cronin et al., 1991; Steinmetz et al., 2014). Even if the QSAR models of Chapter 2 and 
3 are slightly different, they show the same strong relationship between hydrophobicity 
(log P) and toxicity as described for many species (Könemann, 1981; Verhaar et al., 
1991). In both cases CS, used as a threshold (Chapter 2) and as used here (weighted 
regression), improved the aquatic toxicology QSAR. 
Consideration of the QSAR/QSPR models developed in this study shows an 
improvement in the models when CS-weighted regression was utilised. The improvement 
is in both the statistical fit as well as the slope for log P which approaches one when 
employing CS-weighting, i.e. from 0.68 to 0.90 (refer to Eq. 3.5 to 3.6). A slope of one is 
the theoretical optimum, which is commonly associated with models for simple 
unicellular organisms, i.e. the absorption of the compound alone directly into the cellular 
membrane is responsible for narcosis, whereas in higher organisms other factors such as 
distribution and clearance become important. The improvements following the 
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application of CS are consistent with the notion that some historical data are of poor 
quality (Cronin and Schultz, 1996) and demonstrate the utility of an approach such as 
this, where generalistic QSARs are being developed for datasets from various sources and 
of unknown quality. The importance of the compounds with high CS values can be seen 
in Fig. 3.3, when considering that all large CS-circles (representing compounds with 
higher CS) are close to the line of best prediction. The quantity of data and the 
incorporation of statistical data quality make a robust equation with an extensive 
applicability domain – for non-polar narcotics. Clearly this approach could be extended to 
other data compilations for aquatic acute toxicity (Martin et al., 2015).   
The identification of compounds acting by the non-polar narcotic mechanism of action is 
essential to the development of models. Various approaches have been applied to identify 
mechanisms of action including analysis of molecular descriptor space (Schultz et al., 
1997), multivariate analysis of mode and mechanism of action space (Aptula et al., 
2002), definition of molecular fragments (Ellison et al., 2008) as well as the Verhaar 
classification scheme that was applied in this study due to its ease of use following 
coding in the Toxtree software. However, there appear to be a number of anomalies in the 
definition of the non-polar narcosis domain in the Toxtree software. For example, 
aflatoxins (cf. Chapter 2; Fig. 2.5 and 2.6) are identified by the Toxtree software as being 
Verhaar Class 1 compounds (non-polar narcotic) but, in reality, they are potent, 
specifically acting, toxins and therefore do not act as non-polar narcotics, e.g. aflatoxin 
B2 has pTexperimental = 1.17 (CS = 15.4) whereas Equation 3.7 calculates pTpredicted = 0.54 
(Steinmetz et al., 2014). This emphasises that continual development is required of 
decision criteria presented in approaches such as the Verhaar scheme as new knowledge 
and understanding becomes apparent.  
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Overall for both datasets, applying CS as a weighting tool improves the training and 
validation of the QSAR/QSPR models. The improvements are demonstrated as increases 
in R2 (Eq. 3.3 to 3.4 and Eq. 3.5 to 3.6) as a direct result of CS-weighting. Whereas 
increasing t and F values show improvements in the models as a result of weighting by 
CS, the S value does not incorporate weights and so only indicates absolute, unweighted 
error thus it actually increases when the non-weighted regression is compared to the 
weighted regression. Generally the higher the CS for the data associated with a 
compound, the greater the evidence is, in terms of similar results for that compound (refer 
to Fig. 3.2 and 3.3). In the validation process, the RMSECS, which incorporates CS-
weighting, is lower than the standard RMSE. As residuals (fi - yi) of low CS compounds 
are weakened and residuals of high CS compounds are strengthened, the sum of (squared) 
errors of the RMSECS becomes lower than in the conventional RMSE. Therefore this 
approach could be used even for the validation of models where any metric could be 
applied to imply confidence, i.e. without calculating CS. For example a reversed 
Klimisch score (4 as the most reliable; 1 the least) could be used as a weight similar to 
the fuzzy logic approach of Yang et al. (2013). In the context of validation these weights 
then determine to what extent residuals should have impact on the RMSE.  
The CS-weighting approach, whether in model development or validation, is limited by 
the presence of multiple entries for one compound. Thus, if multiple values are available 
for the dataset, more robust models may potentially be built (Steinmetz et al., 2014). This 
robustness and the associated confidence are helpful in reducing uncertainty and hence 
increasing acceptance for regulatory decisions. For example in the context of REACH, 
there is a demand for robust QSAR models to support the toxicological assessment of 
chemicals. The approach described herein could thus be used to support read-across- and 
QSAR-based predictions (Cronin, 2013; Patlewicz et al., 2014). 
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3.5. Conclusions 
The assessment of data quality is not trivial. This study has shown that CS provides a 
means of assessing confidence in data when there are more than a single datum point. 
The CS scores can be applied to develop QSAR models through the use of weighted 
regression, as demonstrated in this study for historical data compilations with known 
variability in the quality of the data. Additionally cross-validation with RMSECS provides 
a measure of the robustness of an equation utilising metrics (here CS) for weighting. 
The results from Chapter 3 show that a novel method, which is applying statistical data 
quality within modelling, leads to robust QSAR/QSPR models (as published in Steinmetz 
et al. 2015b). Beside the methodological value, particularly the QSPR model is very 
useful in the context of risk assessment of cosmetic ingredient – hence the relevance for 
the COSMOS project. Chapter 4, which deals with dermal absorption, applies similar 
principles of physico-chemical properties. The two main differences are Chapter 4 deals 
with a set of rules (similar to an expert systems) and only specific applicability domain of 
substances (i.e. hair dyes and associated compounds). Even if the data and the applied 
methods are different, both chapters share the same biochemical principles of skin 
permeation. 
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4. Classifying dermal absorption of cosmetic ingredients based on 
physico-chemical properties to facilitate safety assessment* 
4.1. Introduction 
As described in Chapter 1, the European Cosmetic Regulation (EC 1223/2009) requires 
that the ingredients in cosmetic products, as well as the formulation itself, need to be safe 
for human usage and it is the responsibility of the manufacturer to ensure this. The safety 
assessment of a product is generally based on individual safety assessments of the 
product’s ingredients. This requires knowledge of individual ingredients (particularly 
those in significant concentration) in a product as well as knowledge about toxicological 
profiling. Furthermore use scenarios and hence exposure patterns of the product are 
required to allow safety evaluation / risk assessment. This information can subsequently 
be used for the calculation of the margin of safety (MoS). The MoS is the ratio of the no-
observed-adverse-effect level (NOAEL) and the systemic exposure dosage (SED), which 
can, for example, be dermal absorption per skin surface and time according to use 
patterns (refer to Equation 4.1). Whereas the NOAEL is typically obtained from repeated 
dose / reproductive toxicity animal trials, the SED can be obtained from in vivo or in vitro 
tests (SCCS/1501/12). 
 
     𝑀𝑜𝑆 =
𝑁𝑂𝐴𝐸𝐿
𝑆𝐸𝐷
           (Eq. 4.1) 
Due to the ban on animal testing in the European cosmetic legislation (refer to Chapter 1) 
and the absence of validated in vitro alternatives, it is no longer possible to obtain 
NOAEL values from in vivo experimentation to calculate the MoS for newly developed 
cosmetic ingredients.  However, considerations of exposure  may be  relevant for instance  
 
*This chapter is based on my contribution to Ates et al. (2015) 
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cosmetic ingredients with negligible dermal absorption may not require systemic 
toxicological assessment. Hence there is great interest in identifying compounds with low 
dermal absorption. If this is the case, then systemic toxicological assessment can 
effectively be waived and safety assessment may be based on local toxicity, e.g. skin 
irritation, corrosion and sensitisation as well as mutagenicity/genotoxicity. 
Dermal absorption means the uptake of chemical substances via the skin, sometimes also 
referred to as percutaneous absorption.  This includes skin permeation as described in 
Chapter 3. However, the main difference in the context of this thesis is that dermal 
absorption data encompasses data on the absorbed quantities of dermally applied 
substances, whereas skin permeability (refer to Chapter 3) exclusively describes the 
permeation through the stratum corneum (Rang et al., 2007a). 
The dermal absorption dataset investigated in this study is based on information 
harvested from the expert opinions of the European Commission’s Scientific Committee 
on Consumer Safety (SCCS). It has a clear focus on hair dyes and associated compounds 
due to their potential toxicity, e.g. adverse effects on mitochondria (Nelms et al., 2015). 
SCCS opinions are publically available and contain summaries of studies on different 
toxicological endpoints, as well as information on dermal absorption and physico-
chemical properties. The information is intended to support product development, 
including internal safety assessment, and regulatory decision-making in the field of 
personal care products. 
The aim of this study was to classify the dermal absorption of cosmetic ingredients. 
Hence rule sets are proposed, which have the potential to support regulatory safety/risk 
assessment. Therefore physico-chemical properties which may affect dermal absorption, 
such as the logarithm of the octanol-water partition coefficient (log P), molecular weight  
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(MW), topological polar surface area (TPSA) and the melting point (MP) were 
investigated. Through many studies in the field of skin permeability, e.g. Potts and Guy 
(1992), Magnusson et al. (2004), and oral absorption/bioavailability, e.g. Lipinski et al. 
(2001), Newby et al. (2015), the relationship between physico-chemical properties and 
permeation through relevant biological barriers has been investigated and discussed 
thoroughly. There is a strong consensus that large, hydrophilic and ionic molecules 
permeate membranes to a lesser extent than small, (moderately) lipophilic and uncharged 
molecules – similar to the skin permeability QSPR in Chapter 2. Regarding the additional 
descriptors; TPSA expresses the polar surface of a molecule, i.e. it correlates with 
hydrogen bonding ability and water solubility, and furthermore MP holds additional 
information on thermodynamical stability (solid-liquid phase change) of a substance. This 
information, which is easily measured (MP) and calculated (TPSA) respectively, might 
support the prediction of in vivo permeation and absorption (Pugh et al., 2000; 
Magnusson et al., 2004). 
 
4.2. Methods 
The dermal absorption data from the SCCS opinions, based on reports from 2000 to 2014, 
were provided by the In Vitro Toxicology and Dermato-Cosmetology research group of 
the Vrije Universiteit Brussel (Ates et al., 2015) as part of a co-operative study in the 
SEURAT-1 Cluster. Two datasets were constructed as follows: dataset A summarises all 
the data without any information on MP and dataset B summarises the data, which 
include measured MP values within the reports. Regarding the classification of dermal 
absorption, i.e. defining the absorption threshold for potential adverse effect, the 
empirically derived values of 1.3% and 2% respectively were chosen (private 
communication with Prof. Rogiers from the Vrije Universiteit Brussel). The dataset is 
attached in Appendix A.3. 
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4.2.1. Data treatment and descriptor calculation/retrieval 
The SCCS dermal absorption data are derived from various methods, e.g. different 
species, varying exposure scenarios etc. Measurements using rat skin were discarded 
from the dataset because of the relatively high uptake when compared to human or 
porcine skin (Ravenzwaay and Leibold, 2004). For compounds with more than one 
measurement per compound arithmetic means were calculated. Descriptors were 
calculated for the parent form of the compound, therefore SMILES strings were first 
neutralised and desalted within MOE (MOE, 2013). Subsequently TPSA and MW were 
calculated using CDK’s molecular properties node within KNIME (KNIME, 2015) and 
log P was calculated using KOWWIN v1.68 within EPI Suite (EPA, 2013). MP was 
extracted from SCCS opinions if available.  
 
4.2.2. Decision trees, clustering and modifying rules 
For each dataset a set of rules, similar to Lipinski's rule of five, has been created in order 
to classify compounds as being associated with a toxicologically significant level dermal 
absorption, i.e. above or lower than the thresholds of 1.3% and 2%. Beside empirically 
derived approximations based on the literature (Potts and Guy, 1992; Magnusson et al., 
2004; Lipinski et al., 2001; Newby et al., 2015; Pugh et al., 2000), the KNIME's decision 
tree learner (KNIME, 2015) employing log P, MW, TPSA and MP (only in dataset B) 
was used to determine relevant combinations of descriptor cut-offs. The decision tree 
learner splits classes in a binary manner by minimising differences towards split points. 
However, to avoid overfitting, final rule sets were defined manually by adjusting rules 
iteratively. Granularity and statistical performance were analysed according to Cooper et 
al. (1979), i.e. comparing sensitivity and specificity. 
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4.3. Results and discussion 
The dermal absorption dataset has been enriched by physico-chemical descriptors. 
Furthermore the data have been split in dataset A (encompassing 116 compounds without 
MP) and dataset B (encompassing 70 compounds including MP). 
 
4.3.1. Results dataset A 
The following physico-chemical cut-offs (based on the KNIME decision tree learner and 
empirical refinement) were defined and applied. These cut-offs represent thresholds for 
increased permeability, hence they are referred to as ‘alerts’ within the context of the 
following rule-based models. 
 MW < 180 Da 
 log P ≥ 0.3 
This implies that compounds with MW < 180 Da and/or log P ≥ 0.3 are more likely to be 
dermally absorbed in a greater magnitude. The results are illustrated in Figure 4.1, which 
shows that as the number of alerts increases the dermal absorption increases.  
 
 
 
 
 
 
 
 
Figure 4.1: Boxplot of log (%) dermal absorption versus number of physico-chemical 
alerts for dataset A (n = 116); the *-symbol describing outliers 
 
Classifying dermal absorption of cosmetic ingredients 
61 
 
If any violation of the rules, i.e. MW < 180 Da or log P is ≥ 0.3, is found, the compound 
will be predicted as potentially highly absorbed (≥1.3%). Table 4.1 shows the results of 
applying the rules to dataset A. The calculation of Spearman's rank correlation led to ρ = 
0.38 (S = 162320, p < 0.001), which indicates a weak (but statistically significant) 
correlation between number of alerts and logarithm of dermal absorption. 
 
Table 4.1: Performance of the rules set for dataset A  
Dataset A Predicted highly absorption Predicted low absorption  Total 
High absorption (≥1.3%) 30 (25.9%) 0 (0%) 30 (25.9%) 
Low absorption (<1.3%) 68 (58.6%) 18 (15.5%) 86 (74.1%) 
Total 98 (84.5%) 18 (15.5%) 116 (100%) 
Sensitivity = 100%  Specificity = 20.9% 
 
On the one hand, the rule set shows high sensitivity, i.e. all 30 compounds with true high 
absorption have been identified, on the other hand specificity is poor; 68 compounds with 
low absorption are predicted incorrectly to have high absorption. However, the design of 
the rule set is beneficial for regulatory purposes due to its cautious/restrictive design. 
 
4.3.2. Results dataset B 
The following physicochemical alerts were defined and applied: 
 MW < 180 Da 
 log P ≥ 0.3 
 MP < 100°C 
 TPSA < 40 Å2 
This implies that compounds with MW < 180 Da and/or log P ≥ 0.3 and/or MP < 100°C 
and/or TPSA < 40 Å2 are more likely to be dermally absorbed. The results are illustrated 
in Figure 4.2, which shows that as the number of alerts increases the dermal absorption 
increases.  
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Figure 4.2: Boxplot of log (%) dermal absorption versus number of physico-chemical 
alerts for dataset B  (n = 70); the *-symbol describing outliers 
 
In contrast to the rule set of dataset A, there are two different ways to use the rule set for 
dataset B. In the first scenario, the conservative approach, if any violation of the rules, i.e. 
MW < 180 Da, log P ≥ 0.3, MP < 100°C or TPSA < 40 Å2, is identified, the compound 
will be predicted as having potentially high absorption (≥1.3%). Table 4.2 shows the 
results of applying the rules to dataset B. The calculation of Spearman's rank correlation 
led to ρ = 0.60 (S = 23111, p < 0.001), which indicates a moderate, statistically 
significant correlation between number of alerts and logarithm of dermal absorption. 
 
Table 4.2: Performance of the rules set for dataset B (scenario 1; “conservative”)  
Dataset B Predicted high absorption Predicted low absorption  Total 
High absorption (≥1.3%) 23 (32.9%) 0 (0%) 23 (32.9%) 
Low absorption (<1.3%) 38 (54.3%) 9 (12.9%) 47 (67.1%) 
Total 61 (87.1%) 9 (12.9%)  70 (100%) 
Sensitivity = 100%  Specificity = 19.1% 
 
In the second scenario, the realistic approach, violation of none or only one rule is 
allowed, meaning that more than one violation of the rule leads to the prediction of high 
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absorption for a compound. The statistical performance of scenario two is expressed in 
Table 4.3. 
 
Table 4.3: Performance of the rules set for dataset B (scenario 2; “realistic”)  
Dataset B Predicted high absorption Predicted low absorption  Total 
High absorption (≥1.3%) 19 (27.1%) 4 (5.7%) 23 (32.9%) 
Low absorption (<1.3%) 18 (25.7%) 29 (41.4%) 47 (67.1%) 
Total 37 (52.9%) 33 (47.1%) 70 (100%) 
Sensitivity = 82.6%  Specificity = 61.7% 
 
Scenario 1 and 2 can be directly compared as they use the same dermal absorption cut-off. 
On the one hand the model based on scenario 2 is a better overall prediction with 
moderate sensitivity (82.6%) and specificity (61.7%) respectively (refer to Table 4.3), on 
the other hand the model based on scenario 1 is very conservative with a maximum 
sensitivity (100%) but poor specificity (19.1%) (refer to Table 4.2). Therefore the 
“conservative” model might be more favourable for regulatory decision-making, due to 
high certainty of practically no dermal absorption when “low absorption” is predicted. 
However, in the third scenario, the flexible approach, a different threshold for dermal 
absorption was taken (2%). The 2% threshold is empirically more favourable than 1.3% 
threshold to classify the dataset B. The violation of one or more rules leads to the 
prediction of a compound having high absorption. All other compounds are classified as 
having low absorption. The performance of the rule set in this scenario is shown in Table 
4.4. 
Table 4.4: Performance of the rules set for dataset B (scenario 3; “flexible”)  
Dataset B Predicted high absorption Predicted low absorption  Total 
High absorption (≥2%) 13 (18.6%) 0 (0%) 13 (18.6%) 
Low absorption (<2%) 24 (34.3%) 33 (47.1%) 57 (81.4%) 
Total 37 (52.9%) 33 (47.1%) 70 (100%) 
Sensitivity = 100%  Specificity = 57.9% 
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When shifting the dermal absorption cut-off to 2%, it is possible to achieve maximum 
sensitivity (100%) while still having moderate specificity (57.9%) (refer to Table 4.4). 
While the assignment of the new dermal absorption cut-off seems to be favourable for the 
model, it is questionable if 2% in vivo dermal absorption is within an acceptable margin 
regarding regulatory assessment (nota bene: the initially suggested cut-off, before 
modelling, was 1.3% based on private communication with Prof. Rogiers). 
Effects of physico-chemical properties on dermal absorption have been confirmed with 
similar concepts as the literature proposes, i.e. that small, uncharged and (moderately) 
lipophilic compounds pass easier through the skin (Potts and Guy, 1992; Magnusson et 
al., 2004; Lipinski et al., 2001; Newby et al., 2015; Pugh et al., 2000). Furthermore 
similar physico-chemical relationships on passing through the stratum corneum were 
confirmed by the QSPR models presented in Chapter 3. The official opinions of the 
SCCS do offer only limited descriptions of the testing protocols, i.e. it would be nearly 
impossible to differentiate high and low data quality based on testing protocols. However, 
differences in the dermal absorption testing methodology are likely to have an impact on 
the potentially poor data quality of some data. Therefore the focus of this study lies, as 
often in applied sciences, on the overall picture by accepting the potential low quality 
associated with the data (refer to Chapter 2 and 3). 
Most cosmetic products are applied topically, which makes dermal absorption the main 
route of exposure. Of course, dermal absorption is only one factor within safety and risk 
assessment, however it is relevant for the calculation of the MoS (as described in Eq. 4.1). 
For compounds with marginally low dermal absorption values (e.g. <0.01%), SED values 
are very low, what may increase the MoS quite dramatically. When additionally 
considering the usage of the uncertainty factor, for example for the animal to human 
extrapolation, an experimental NOAEL value might not contribute as much as expected 
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to the final safety evaluation. Furthermore it must be noted that rodent data, from which 
NOAEL values are based on, are not always of that precise. When Gottmann and 
colleagues investigated two datasets with experimental rodent carcinogenicity data, they 
only found a concordance of 57% between duplicates from different resources (Gottmann 
et al., 2001). Keeping this mind, read-across and local QSARs (e.g. within one 
functional/chemical class of cosmetic ingredients) may be excellent tools to allow for the 
assessment of NOAELs – particularly as experimental testing to establish a NOAEL is no 
longer feasible for cosmetic ingredients.  
 
4.4. Conclusions and perspectives 
In this study an in silico approach to predict (or to better classify) dermal absorption of 
chemicals was developed. Several models were developed with differing sensitivity and 
specificity depending on the dermal absorption thresholds defined for classification and 
the availability of melting point data. It must be pointed out that, as shown by the 
performance of the models (Tables 4.2 and 4.3), high sensitivity usually compromises 
specificity and vice versa. It is common practice in risk assessment and regulatory affairs 
to consider, or plan for, worst-case scenarios by assuming “conservative” numbers in 
cases of doubt, for example when few or no adequate data are available. However, a 
conservative approach at multiple levels can cumulatively add up to an overly cautious 
number, e.g. a very low MoS value. Generally, from a scientific point of view, the most 
realistic equation, model or even “educated guess” should be used at every step (exposure, 
absorption, MoA etc.) within any risk assessment approach. Rounding up/off to a 
conservative, regulatory acceptable value should be done exclusively at the end of the 
approach. It is more transparent to increase the uncertainty factor at the end of the 
mathematical part of the risk assessment than using skewed equations and models, for 
example with 100% sensitivity and poor specificity (refer to Tables 4.1 and 4.2). 
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Nevertheless, all tools presented in this study have the potential to support risk 
assessment, at least on the SED side of the equation. According to the challenge, i.e. 
dealing with hair dyes etc. and splitting the data at 1.3% dermal absorption, models are 
presented with attributes such as “conservative”, “realistic” and “flexible” (threshold at 
2%).  
Beyond the concrete dermal absorption classification models of hair dyes etc., this study 
serves as well as a demonstration of how to create simple classification models for 
dermal absorption to support non-testing approaches in the consumer and personal care 
industry. Both of these interpretations of this study, as a model and as a blueprint for 
other classification models, are relevant for the assessment of cosmetic ingredients, and 
hence relevant for the COSMOS project. However as dermal absorption is only one pillar 
of the assessment of cosmetic ingredients, toxicity-driving mechanisms need to be 
investigated as well. Therefore Chapter 5, 6 and 7 deal with mechanistically-based 
modelling with a specific focus on liver toxicity (as a relevant example for cosmetic 
ingredients). 
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5. Screening chemicals for receptor-mediated toxicological and 
pharmacological endpoints: Using public data to build screening 
tools within a KNIME workflow* 
5.1. Introduction 
The assessment of potential toxicants is a multidisciplinary task. Whilst the previous 
chapters dealt with issues, such as data quality (Chapters 2 and 3) and kinetics (Chapters 
3 and 4), the following Chapters (5 to 7) deal with mechanistically based modelling and 
the identification of the molecular initiating events of untested compounds. Hence the 
following chapters provide innovative tools and methodologies for hazard identification.  
Generally speaking, predicting and understanding the properties of new chemical entities 
is not trivial, whether in the development of novel pharmaceuticals or in assessing 
potential toxicity. However, in silico, QSAR and read-across approaches provide a means 
of rapidly obtaining information (Blackburn and Stuard, 2014; Cronin et al., 2013; 
Patlewicz et al., 2013). Such models can be supported by, or developed from, 
mechanistic understanding (Zhu et al., 2014). Additionally the concept of the AOP, i.e. 
describing a sequence of causally linked events at different biological levels, is 
increasingly being applied to investigate adverse effects (Vinken et al., 2013). As 
described more in detail in Chapter 1 (Section 1.4.2), models may be developed from 
knowledge of the first key event of an AOP, the molecular initiating event (MIE). In AOP 
terminology the MIE is followed by cellular and organ responses, which may ultimately 
result in an adverse effect to an organ, organism or population (Ankley et al., 2010). The 
MIE represents the initial interaction between a molecule and a target. Examples of MIEs 
include  covalent  binding  to  DNA  and,  of  relevance  for  this  study,  receptor binding 
* This chapter is based on a published article (Steinmetz et al., 2015a) 
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(Gutsell and Russell, 2013; Allen et al., 2014). In pharmacology the mode of action, 
similar to an AOP, incorporates a MIE which describes how a compound interacts with 
specific proteins, e.g. receptors, carriers and enzymes. However, rather than providing the 
framework for describing the processes behind an adverse effect, the aim in 
pharmacology is to achieve a beneficial effect, such as the prevention or treatment of a 
disease (OECD, 2012; FDA, 2013). 
Analogous to pharmacology, toxicity may also be brought about by interactions with 
specific proteins, such as receptors. Endocrine disruptors, for example, are a class of 
toxicants known to cause their effects by receptor-mediated mechanisms. As such, 
models for endocrine disruption are usually built around knowledge of receptor 
interactions, e.g. binding to the oestrogen receptor. For instance, one approach to 
modelling these effects has been proposed recently by Kolšek and colleagues (2014) who 
developed a tool to identify nuclear receptor ligands based on AutoDock Vina; a freeware 
to investigate ligand-protein-interactions (Molecular Graphics Laboratory, 2014). 
Limitations of this type of approach are associated with several of the typical issues of 
docking. First, nuclear receptors, particularly the non-steroid receptors, are considered to 
be flexible (Nettles et al., 2007). An inflexible docking model, such as AutoDock Vina, is 
unlikely to cope with the diversity of ligands including, for instance, full and partial 
binding modes as well as inverse agonists and antagonists. The second limitation, when 
docking is applied on its own, is that kinetics (on a cellular level) are systemically 
ignored, which might be vital for in vivo biological activity. The physico-chemical 
properties of the ligand play an important role, particularly for absorption and distribution 
at a histological and cellular level, which may all eventually contribute to, or define, 
target-organ-toxicity (Campbell, 1983; Davis and Riley, 2004). 
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The current study focuses on the retinoic acid receptor (RAR), a target relevant for 
pharmacology and toxicology in equal measure. The RAR is a nuclear receptor which can 
be divided into three subtypes, RAR-α, RAR-β and RAR-γ. Bound together with the 
retinoid X receptor (RXR) as a heterodimer, RAR regulates genetic expression. All three 
subtypes of the RAR are activated by all-trans retinoic acid and 9-cis retinoic acid, which 
are derivatives of vitamin A (Liu et al., 2014). Ligands are used in the treatment of 
dermal diseases, e.g. Acne vulgaris, Psoriasis vulgaris, Keratosis pilaris and specific 
types of cancer, such as acute promyelocytic leukaemia (Alizadeh et al., 2014; Allen and 
Bloxham, 1989; Dicken, 1984; Leyden et al., 2005). 
The toxicological effects of RAR agonists include changes in lipid metabolism, which 
may cause hepatosteatosis leading to liver inflammation, fibrosis and eventually liver 
failure. Teratogenic effects and neural disorders, such as nausea and headache, have been 
also reported from retinoids (Adams, 1993; Biesalski, 1989; Moya et al., 2010; Shalita, 
1988). There is, therefore, a great need to develop tools to identify compounds which 
show these effects. 
There are many open source software applications and open access databases supporting 
modern life sciences and informatics. A number of these open access/source technologies 
can be utilised to develop tools and approaches for predictive and/or computational 
toxicology. Some technologies relevant to this study are described below. 
The KoNstanz Information MinEr (KNIME) technology is a freely available software to 
analyse and mine data, as well as to build and evaluate predictive models. The software is 
based on a graphical user interface utilising so called “nodes” as key units to alter and 
process data in a “workflow”. The basic KNIME workflow technology, as well as many 
nodes and add-ons for chemo-informatics, is available from www.knime.org. Many types  
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of data can be handled, including chemical formats, such as the Simplified Molecular 
Input Line Entry System (SMILES) and SMiles ARbitrary Target Specification 
(SMARTS) (Daylight, 2014). KNIME has a strong community of developers building 
additional nodes for chemo-informatics applications (amongst others), to edit data, 
calculate physico-chemical properties, analyse structural features etc. It has been shown 
to be useful in developing workflows for screening tools in the context of predictive 
toxicology (Saubern et al., 2011; KNIME, 2013). Furthermore, many other programming 
languages, such as R, Python or Perl, can be used within a KNIME workflow (Berthold et 
al., 2007; KNIME, 2014; Richarz et al., 2013). 
With regard to biological activity, there are an increasing number of resources available 
to retrieve information. For instance, ChEMBL is a database of bioactive molecules 
comprising over 1.5 million compounds and over 9,000 biological targets. Activity values 
are reported for a variety of endpoints including Ki, Kd, AC50, IC50, and EC50. The 
database is curated manually and maintained by the European Molecular Biology 
Laboratory (ChEMBL, 2014). A good example of the application of ChEMBL and the 
utilisation of its resources was published by Czodrowski (2013). In that study, a detailed 
analysis of ChEMBL hERG assay data was used to build classification models relevant 
for drug development and demonstrated the applicability of these data for modelling and 
the value that may result from data mining. 
Another valuable resource is the Protein Data Bank (PDB, 2014) which contains over 
100,000 crystallographic structures of proteins such as receptors, transporters and 
enzymes. A quarter of these protein structures are of human origin, the other structures 
are from other mammals (mainly rodents) and bacteria. For some proteins, such as the 
RAR, there are data for several subtypes, species and ligands (Berman et al., 1999). 
Besides the linked publications for every entry, ligand-protein-interactions can be 
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investigated with specific software, for example PyMOL (2014). Visualisation of protein 
structures of targets, such as receptors, transporters and enzymes, and their corresponding 
ligands, helps to understand ligand-protein-interactions, e.g. hydrogen bonds between the 
ligand and the ligand-binding-domain of the protein. 
Whilst there is a growing number of computational resources, some of which have been 
developed for computational toxicology, up until now there has been little effort, and few 
publications, demonstrating the utility of combining these disparate sources of 
information. The aim of this investigation, therefore, was to present a hands-on approach 
to develop screening tools applicable for many pharmacological and toxicological 
challenges. The methods applied are based firstly on gathering publically available data 
on RAR ligands (from ChEMBL and PDB) and secondly extracting information on 
physico-chemical space and structural features that are relevant to activity. Thirdly, this 
information was used to build a rule-based screening tool within KNIME. The purpose of 
the screening tool in this study was to identify potential RAR ligands. RAR is only one 
example target, i.e. this approach was designed to provide a framework that can, in 
principle, be used to create screening tools for other receptors should sufficient data be 
available. 
 
5.2. Methods 
The RAR and its ligands were investigated solely using freeware (nota bene: PyMOL is 
free for academic users only) and open access databases. 
 
5.2.1. Analysis of RAR ligands using the PDB 
The PDB 3.3 was searched for human RAR structures, i.e. RAR-α, RAR-β and RAR-γ 
(PDB, 2014). The structures obtained were investigated visually with regard to their 
ligand-protein-interaction within PyMOL 1.3 (PyMOL, 2014). Common structural 
Screening chemicals for receptor-mediated endpoints 
72 
 
features of the ligands, particularly when apparently responsible for similar ligand-
protein-interactions, were extracted manually. The extracted structural features combined 
information about molecular distances and molecular electronic forces, which may be 
responsible for hydrogen bonding or the occupation of lipophilic pockets. Subsequently 
the structural features were coded manually into SMARTS strings. These SMARTS 
strings were later used in the rule-based workflow to predict potential RAR ligands. 
 
5.2.2. Extracting data from ChEMBL 
The ChEMBL_19 database was searched for the target “RAR” (ChEMBL, 2014). Human 
data from compounds with Ki (binding affinity), Kd (dissociation constant), AC50 (50% 
activity in molar units) and EC50 (50% effect concentration in molar units) values towards 
RAR-α, RAR-β and RAR-γ were downloaded, combined and sorted by the pChEMBL 
value. The pChEMBL value is an approach to standardise different types of activity 
values (Bento et al., 2013). Every compound with a value of five or greater was regarded 
as being active due to binding towards RAR. This is consistent with the activity 
interpretations of the ChEMBL database. 
 
5.2.3. Physico-chemical property calculation 
The physico-chemical properties of RAR ligands were calculated using the CDK node for 
molecular properties within KNIME 2.9.4 (including community contributions) (KNIME, 
2014). Ranges (i.e. minimum and maximum values) for different types of calculated 
descriptors for the active ligands were studied including: vertex adjacency information 
magnitude (VAIM) for structural complexity, number of rotational bonds (RB) for 
flexibility, molecular weight (MW) for molecular size and the logarithm of the octanol-
water partition coefficient (XLogP; CDK’s version of the log P) for lipophilicity. These 
four descriptors and their calculated property ranges were utilised to give an insight into 
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the physico-chemical applicability domain (or chemical property space) of active RAR 
ligands. 
 
5.2.4. Building rules for the screening workflow 
The analysis of the PDB has provided structural features coded as SMARTS strings; 
whilst the analysis of the ChEMBL dataset provided physico-chemical property ranges. 
Both describe the necessary features for compounds to be active RAR ligands. These 
features can be interpreted as rules, where compliance and violation will distinguish 
between RAR ligands and non-ligands respectively. These rules, characterising the 
physico-chemical space (CDK node for molecular properties) and structural features 
(Indigo substructure matcher), were written into a KNIME workflow. When executed, 
this KNIME “screening workflow” can identify potential RAR ligands. 
 
5.2.5. Testing the screening workflow 
The RAR ligands, identified from the ChEMBL dataset, were used to test if all active 
compounds were identified by the “screening workflow”. Since no external validation 
dataset was available, the dataset of hepatotoxicants provided by Fourches and colleagues 
was screened. The Fourches dataset is a large, chemically diverse dataset (951 
compounds), which contains hepatotoxic and non-hepatotoxic drug molecules, including 
several RAR ligands (Fourches et al., 2010). As the number of RAR ligands is unknown, 
the performance statistics (sensitivity, specificity etc.) of the screening workflow cannot 
be calculated; thus the predictions for the Fourches dataset are for illustration only. This 
approach cannot be considered a full validation as the Fourches data could include liver 
damage by a number of mechanisms not restricted to RAR binding. 
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5.3. Results 
This study utilised a number of data sources, such as the PDB for ligand-protein-
interactions and the ChEMBL database for chemical structures of active compounds 
against RAR. 
 
5.3.1. Ligand-protein-interaction in RAR  
20 human RAR protein structures bound to different ligands were retrieved from the PDB. 
These were 4JYG, 4JYH, 4JYI, 4DQM, 4DM6, 4DM8, 3KMR, 3KMZ, 1XAP, 1FD0, 
1FCX, 1FCY, 1FCZ, 1DSZ, 1EXA, 1EXX, 3LBD, 4LBD, 2LBD and 1HRA (PDB, 
2014). Independent of receptor subtype and ligand, as proposed by Klaholz and 
colleagues (2000), the hydrogen bond between an oxygen (most often from a carboxylic 
group) and the arginine (here: R278) was found to be of great importance for the ligand-
protein-interaction. Figure 5.1, for example, indicates the carboxylic acid of retinoic acid 
binding to amino acid R278. 
 
 
Figure 5.1: Retinoic acid binding to human RAR gamma (3LBD), highlighting the distance of 
2.1 Å between R278 and an oxygen of the carboxylic group of retinoic acid (investigated with 
PyMOL 1.3) 
Screening chemicals for receptor-mediated endpoints 
75 
 
5.3.2. Substructures extracted from the ChEMBL database  
251 active RAR ligands (pChEMBL ≥ 5) were identified from the ChEMBL database and 
these are recorded in Appendix A.4. Common structural features to the ligands, as 
identified from analysis of the chemical properties and visual appearance, were flexibility, 
a lipophilic scaffold and a terminal hydrogen acceptor (e.g. the carbonyl of a carboxylic 
group). This information about essential molecular substructures and properties was 
coded as SMARTS strings, as shown in Table 5.1. The first rule is for a carboxylic group, 
an amide or a ring structure derived from these structures, e.g. 1,2,4-oxadiazol-5-one, 
which is required to be at the end of a predominantely aliphatic chain. Specific aromatic-
containing scaffolds are possible too (refer to Fig. 5.2), and these are also recognised by 
the substructures identified in Table 5.1. Regarding the second rule, the ring structure, e.g. 
cyclohexene in retinoic acid, can be methylated or halogenated, as the ChEMBL dataset 
of active RAR ligands revealed. 
Table 5.1: Structural features of ligands converted to rules for the KNIME workflow 
Rule SMARTS string  Structural feature 
 
Arginine (R278) 
Binder 
 
 
 
 
 
and 
 
 
Methylated or 
halogenated ring-
system 
 
*~*~*~*~*~*~*~*~*~*~*~[#6](=O)~[#8] 
or 
*~*~*~*~*~*~*~*~*~*~*~[#6](=O)~[#7] 
 
 
 
*1~*([F,Cl,Br,I,C])~*~*~*~*~1 
 
 
 “A” or “*” is a wild card, i.e. it could represent any heavy atom 
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Figure 5.2: Structures of 4-{[(4-bromo-3-hydroxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2- 
naphthalenyl)carbonyl]amino}-2,6-difluorobenzoic acid (A) and 4-({5,5-dimethyl-8-[4-(tri-
fluoromethyl)phenyl]-5,6-dihydro-2-naphthalenyl}ethynyl)benzoic acid (B) illustrating the 
flexible nature, lipophilic character and terminal hydrogen bonding group of two chemically 
diverse potent RAR ligands 
 
 
5.3.3. Physico-chemical properties  
The ranges of the physico-chemical properties calculated for the 251 ChEMBL-derived 
RAR ligands are shown in Table 5.2. The ranges were converted into rules which can be 
used as exclusion critera, i.e. if a compound has a MW of greater than or equal to 500 Da, 
then it is, according to the retrieved data, unlikely to be a RAR ligand. The rules have 
some structural basis, i.e. VAIM and MW express the complexity and the size of the 
molecule respectively, and XLogP describes overall molecular lipophilicity. Besides this 
basic information, RB indicates the required flexibility of the (lipophilic) chain. 
Generally speaking, the chemical space covers small, lipophilic molecules with certain 
degrees of flexibility within the lipophilic scaffold. This is consistent with our 
understanding of the properties of the ligands and their impact on receptor binding. When 
dealing with continuous data, margins of error have been applied manually to the rules, 
e.g. a lower limit for XLogP being 2.00 instead of 2.03 (refer to Table 5.2) was chosen. 
Whilst these are arbitrary, they provide a usable buffer. 
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Table 5.2: Physico-chemical property ranges of the RAR ligands and derived rules 
Descriptor Min  Max Rule  
RB:  4 23      → ≥ 4 
VAIM:  5.46 6.40      → 5 to 6.5 
MW:  278.13 488.25      → < 500 
XLogP: 2.03 10.18      → ≥ 2.00 
 
 
5.3.4. Building the KNIME workflow  
A KNIME workflow, which can be downloaded from Appendix C.1, was created 
combining structural features based on the information from PDB and physico-chemical 
rules based on the ChEMBL dataset. The workflow is shown diagrammatically in Figure 
5.3. The workflow takes the compound of interest through molecular input, 
implementation of physico-chemical and structural rules in turn, resulting in an output of 
whether the compound is in or out of “binding space”. In more detail, the chemical 
structure of interest is imported as a SMILES string. Subsequently, physico-chemical 
properties are calculated and the exclusion criteria (refer to Table 5.2) are applied. 
Following this, the structural rules from Table 5.1 are applied. In this part of the 
workflow, the input SMILES strings, which have already passed the physico-chemical 
rules, are run against a set of SMARTS strings, looking for matches regarding rule 1, the 
arginine binder, and rule 2, the methylated/halogenated ring-system (refer to Table 5.1). 
If a compound’s calculated physico-chemical properties are within the defined ranges 
(refer to Table 5.2), i.e. it lies within the applicability domain, and contains the relevant 
structural features (refer to Table 5.1), then the compound is classed as having the 
possibility of being an active RAR ligand. If a compound is outside the calculated 
physico-chemical ranges of Table 5.2 or does not contain the structural features (refer to 
Table 5.1), it is classified as being inactive towards RAR. Finally the workflow, as it is 
built in Figure 5.3, exports a csv-file gathering the potential RAR ligands. 
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Figure 5.3: KNIME workflow to screen for potential RAR ligands 
 
 
5.3.5. Evaluating the workflow: Screening two datasets 
The workflow was used to screen the 251 active compounds identified from the 
ChEMBL dataset with all compounds being identified as RAR ligands. 109 of 951 
compounds in the Fourches dataset (Fourches et al., 2010) were identified as being RAR 
ligands. Beside retinoids and retinoid-similar structures, some steroids and structurally 
diverse drugs, such as amineptine (tricyclic antidepressant) and cocaine (tropane alkaloid) 
were identified as potential RAR binders. The Fourches dataset does not contain 
information on RAR activity, so performance statistics, such as Cooper statistics (Cooper 
et al., 1979), i.e. false positive ratio, sensitivity etc., are not meaningful in this context. 
 
5.4. Discussion 
Extrapolating from chemistry to pharmacology/toxicology is a non-trivial, often even 
impossible, task. However, it is recognised that assessing chemicals for their 
pharmacological and toxicological properties is of great importance for industry and 
Screening chemicals for receptor-mediated endpoints 
79 
 
regulatory agencies. The AOP framework is increasingly seen as providing usable 
information for modelling as it describes the linkage between the (bio)chemistry of the 
MIE and the potential adverse effect on individuals and populations (Gutsell and Russell, 
2013). A key challenge remains in the prediction of chronic toxicity, particularly modes 
of action relating to organ level toxicity. New technologies have the potential to exploit 
the wealth of data that will be delivered from modern database approaches such as 
ChEMBL and increasing reporting of information from molecular biology. To exploit 
these data, tools and strategies, such as data mining, knowledge extraction techniques and 
(chemo-)informatics tools, are required. Particularly in risk assessment, the identification, 
characterisation and application of chemistry from the MIE of an AOP is an increasingly 
commonly used method to “group” or form categories of similar compounds (Vinken et 
al., 2013; Ankley et al., 2010).  
Grouping is a crucial element in the further use of predictive toxicology approaches, such 
as read-across or QSAR and is best undertaken from a mechanistic standpoint (Blackburn 
and Stuard, 2014; Patlewicz et al., 2013; Cronin et al., 2013; OECD, 2012). One of the 
key challenges for grouping compounds is the definition of similarity. The mechanistic 
framework provided by the AOP paradigm gives a rational basis to developing chemistry 
based alerts (from the MIE) for grouping and ultimately confirming group membership 
using data from assays representing key event(s).  
This study has applied innovative methods to obtain structural information relating to an 
important MIE. This has been achieved by investigating protein-ligand binding data and 
physico-chemical properties. Thus, screening a toxicity dataset with the RAR ligand 
workflow may help to identify compounds acting by the same mechanism and therefore 
belonging in the same group. For such a group of compounds there is a greater likelihood 
of developping mechanistically valid, robust QSARs (OECD, 2014; OECD, 2012; Enoch 
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et al., 2011; Patlewicz et al., 2013). In drug design, there is an interest in identifying 
potent RAR agonists to address several types of cancer and skin diseases (Alizadeh et al., 
2014; Leyden et al., 2005; Allen and Bloxham, 1989; Dicken, 1984). The interest may lie 
in advances towards the receptor-specificity (Vaz and de Lera, 2012; Schinke et al., 
2010), i.e. significant activity for certain receptor subtypes, or pharmacokinetics (el 
Mansouri et al., 1995), e.g. targeted drug localisation. Both strategies may lead to RAR 
agonists with fewer side effects or better risk-benefit ratios. 
In this study information from a set of 251 active RAR ligands from ChEMBL and 20 
crystal structures of ligand-protein-interactions from the PDB was extracted and 
investigated to build a screening workflow predicting potential RAR ligands. The set of 
active RAR ligands is based on Ki, Kd, AC50 and EC50 values, which means beside 
agonists, the dataset is also likely to contain antagonists. However, structural and 
physico-chemical information on antagonists is regarded as beneficial to predict agonists, 
as both share many chemical features. The disadvantage of this procedure is a higher 
likelihood of predicting false positives, i.e. predicting antagonists as being active. 
However as a result of the precautionary nature of this approach, potential drug 
candidates in drug discovery and potential toxicants should be identified by the screening 
workflow. 
As proposed by Klaholz and colleagues (2000) and confirmed by this study, all ligands 
are small, flexible compounds with lipophilic (mostly aliphatic) scaffolds and a (more or 
less) terminal polar functional group, for example, an amide or a carboxylic acid, which 
creates a hydrogen bond with arginine, e.g. R278 (PDB, 2014; Klaholz et al., 2000). 
Potent ligands contain at least one ring structure in the aliphatic scaffold. Furthermore, 
ring structures may be halogenated, as this does not decrease lipophilicity, such as the 
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compounds illustrated in Figure 5.2, which are highly potent RAR-α binders (Beard et al., 
2002; Johnson et al., 1999). 
Figure 5.2 also illustrates the lipophilic (mostly aliphatic) scaffold. As long as flexibility 
and lipophilicity are not greatly impaired, compounds with aromatic rings and amides 
within their scaffold are potential ligands. This explains the large number of wild cards 
within the SMARTS strings (refer to Table 5.1). These wild cards, which are expressed 
with a “*”, represent any heavy atom and the wild card bond expressed with a “~” 
represents any type of bond. On its own the SMARTS strings developed seem not to be 
very specific, however due to the rule-based combination of SMARTS strings and the 
applicability domains defined by physico-chemical attributes, the RAR ligands can be 
identified with a certain degree of specificity. The exact degree of specificity cannot be 
calculated, but when observing the predictions for the Fourches dataset (Fourches et al., 
2010), where 109 potential RAR ligands out of 951 drug-like compounds were predicted, 
the outcome implies a certain degree of specificity – or better, selectivity. According to 
the analysis of the Fourches dataset, 85 compounds of the 109 predicted RAR ligands are 
hepatotoxic. The RAR actives from the ChEMBL dataset were all correctly predicted, 
which again confirms the indication of high sensitivity. 
A screening workflow, as designed as in this study, is assumed to be more sensitive than 
specific, according to the terminology of Cooper and co-workers (1979). However, as 
“conservativeness” is relative, it should be pointed out that KNIME allows for the easy 
adjustment of workflows – without mastering computer language; parameters, thresholds 
and alerts can be changed intuitively. Furthermore it should be observed that the purpose 
of these kind of screening tools is not to replace in vitro assays or any other in silico 
investigation. The main application lies in tasks, such as prioritisation, or as a valuable 
part of an elaborated consensus model (refer to an integrated testing strategy) and it can 
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also assist in the rational grouping of compounds assisting in read-across to predict 
activity and fill data gaps. It is noted that placing this knowledge in the context of the 
AOP framework allows for grouping and read-across to be supported with evidence from 
assay for other key events (Tollefsen et al., 2014). 
 
5.5. Conclusions 
A novel approach to build screening tools solely with freeware (at least for academia) and 
open access databases has been described. The flexible design within KNIME allows for 
adjustment and combination of workflows individually regarding their purpose and their 
specific endpoints. Furthermore a prediction tool for RAR ligands, as an example for 
toxicology and pharmacology in equal measure, is presented, which may help to identify 
potential new drugs and toxicants. This study has also provided new, transparent, 
knowledge regarding the binding of ligands to RAR which may be useful in a number of 
contexts. 
This study of a novel methodology to identify ligands has been published (Steinmetz et 
al., 2015a). The Appendix contains the dataset (A.4), the rule set (B.2) and the KNIME 
workflow (C.1). Of course, in terms of risk assessment and the identification of potential 
toxicants RAR ligands are only one of a myriad of chemical groups. To include some 
further relevant groups, an extension of this approach towards further NRs is presented in 
Chapter 6. While the methods of Chapter 5 and 6 are very similar, a different method 
(using a different type of data) has been used in Chapter 7 – there, structural alerts for 
liver toxicity have been created. 
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6. Identification of nuclear receptor ligands associated with 
hepatotoxicity* 
6.1. Introduction 
Chapter 5 provided an illustration of how innovative methods could be applied to develop 
workflows to predict potential RAR binders. The work in Chapter 6 extends this 
approach to further nuclear receptors (NRs). NRs belong to a large group of ligand-
inducible transcription factors highly relevant to toxicology. The expression of target 
genes is mediated and inhibited by the presence or absence of endogenous ligands 
respectively. The regulated genes are associated with a variety of physiological processes, 
such as metabolism, development and reproduction (Wang and LeCluyse, 2003). NRs are 
well characterised with regard to their protein structure; at the N-terminal there is a DNA-
binding domain (DBD), and at the C-terminal there is a ligand binding domain (LBD). 
NRs exist as monomers and (hetero- and homo-)dimers, for example the liver X receptor 
(LXR) is bound to the retinoid X receptor (RXR) (Maglich et al., 2001; Wang and 
LeCluyse, 2003).  
There are two main types of NRs: Type I receptors are usually found in the cytoplasm 
and are linked to the heat shock protein 90 (HSP90) which assists in the folding of the 
NR and protects it from heat stress. Type I ligands travel to their specific NR target 
through the bloodstream bound to a steroid binding globulin. Ligand binding occurs 
within the cytoplasm before entering the nucleus. After dissociation of HSP90, 
homodimerisation and binding to the hormone response element is initiated, which finally 
promotes the target gene expression via TATA (5’-TATAAA-3’) binding protein, 
transcription  factor II B,  RNA  polymerase II  etc.  (Kersten et al., 2000;  Maglich et al., 
 
* This chapter is based on my contribution to Mellor et al. (2015) 
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2001). Type II ligands bind to the NR complex within the nucleus. Ligand binding causes 
dissociation of co-repressors and association of co-activators, for example to inhibit 
histone deacetylases whose enzymatic activity is responsible for coiling DNA – which is 
unfavourable for protein expression (Sonoda et al., 2008). On a molecular level, the DBD 
consists of two zinc fingers that recognise specific DNA sequences and the LBD contains 
the ligand-dependent activation function - responsible for ligand-protein-interactions 
similar to other pharmacologically relevant receptors. NR ligands are usually small, 
moderately lipophilic compounds, e.g. steroids, retinoids, fatty acids (Maglich et al., 
2001; Moya et al., 2010). Many NR ligands are associated with liver toxicity, in 
particular fatty liver (hepatosteatosis) and the pathways responsible have been 
demonstrated for many NRs (refer to Table 6.1) (Moya et al., 2010; Vinken, 2013; Sahini 
and Borlak, 2014). In this study there is a focus on ligands of the RAR (refer to Chapter 
5), the peroxisome proliferator-activated receptor (PPAR), the liver X receptor (LXR) 
and the retinoid X receptor (RXR) which are associated with genetic expression towards 
hepatic lipid accumulation and de novo fatty acid synthesis (Moya et al., 2010; Vinken, 
2013; Sahini and Borlak, 2014). Beside the significant hepatosteatotic effects of many 
NRs, the farnesoid X receptor (FXR) is also investigated in this study. The exact role of 
FXR within lipid homeostasis is not clear yet, but due to its cholestasis promoting effects, 
it is relevant for hepatotoxicity as well (Vinken, 2015). Similar to the approach described 
for RAR ligands in Chapter 5 (Steinmetz et al., 2015a), it is possible to build KNIME 
workflows for other NR targets relevant for hepatosteatosis (Moya et al., 2010; Sahini 
and Borlak, 2014). 
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Table 6.1: Summary of studied NRs and relevance to hepatosteatosis and hepatotoxicity 
NR name NR subtypes Relevance for hepatosteatosis References 
 
Retinoic acid 
receptor (RAR) 
 
 
Peroxisome 
proliferator-
activated receptor 
(PPAR) 
 
 
Liver X receptor 
(LXR) 
 
 
 
Retinoid X 
receptor (RXR) 
 
 
Farnesoid X 
receptor 
(FXR) 
NR1B1 (α-RAR) 
NR1B2 (β-RAR) 
NR1B3 (γ-RAR) 
 
 
NR1C1 (α-PPAR) 
NR1C2 (β/δ-PPAR) 
NR1C3 (γ-PPAR) 
 
 
 
NR1H3 (α-LXR) 
NR1H2 (β-LXR) 
 
 
NR2B1 (α-RXR) 
NR2B2 (β-RXR) 
NR2B3 (γ-RXR) 
 
 
NR1H4 (α-FXR) 
NR1H5 (β -FXR)* 
All three subtypes are present in 
the liver. There are multiple 
theories for hepatic lipid 
accumulation. 
 
α-PPAR is most present in the 
liver. Increased hepatic 
peroxisome expression is 
associated with lipid 
accumulation. 
 
Both subtypes present in the 
liver; increasing cholesterol/ 
lipid synthesis. 
 
 
Heterodimerisation with RAR, 
PPAR and LXR, i.e. ligands 
support above described NR 
mechanisms. 
 
Mostly present in liver and 
adrenal cortex, FXR activation 
is not associated with 
hepatosteatosis, but associated 
with jaundice and cholestasis.  
 
BioGPS, 2015; 
Moya et al., 2010; 
Hewitt et al., 2013 
 
 
BioGPS, 2015; 
Wang et al., 2002 
 
 
 
 
BioGPS, 2015;  
Schultz et al., 2000 
 
 
Pérez et al., 2012; 
Sahini and Borlak, 
2014 
 
 
BioGPS, 2015; 
Vinken, 2015 
*No data on β-FXR found; α-FXR and FXR often used as synonyms 
 
It must be pointed out that the different NR subtypes (refer to Table 6.1) are structurally 
very close to each other and therefore often bind to the same ligands with similar affinity 
(Steinmetz et al., 2015a). RAR and RXR share the same ligands, whereas RXR appears 
to be more ligand-specific (Minucci et al., 1997). Furthermore, it must emphasised that 
the role of RAR/RXR agonists regarding their hepatosteatotic mechanisms is not fully 
understood and has promoted a much, sometimes controversial, discussion in the 
scientific literature (Moya et al., 2010; Sahini and Borlak, 2014).  
Hepatosteatosis is a multifactorial condition, which is usually triggered by a combination 
of drugs and (fatty) diet. Depending on the degree of lipid accumulation, the condition 
may lead to a non-alcoholic steatohepatitis (NASH), a chronic liver inflammation which 
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may lead to fibrosis and eventually liver failure. Prevalence in the European population is 
about 30% for hepatosteatosis with 10% to 20% developing NASH, i.e. there is public 
interest in identifying substances contributing to hepatosteatosis (Schattenberg and 
Schuppan, 2011; Sahini and Borlak, 2014). Hence the aim of this chapter was to build a 
tool which enables the identification of potential ligands for NR-associated hepatotoxicity 
ligands based on the ligands’ inherent chemical information. 
 
6.2. Methods 
Due to the functional similarity of NR-subtypes and the opportunity to compile large 
datasets from ChEMBL and PDB, four NR-workflows have been developed: 
 RAR/RXR 
 PPAR 
 LXR 
 FXR (only α-FXR) 
 
6.2.1. Analysis of ligand-protein interaction 
The PDB 3.3 was searched for human NR structures for all relevant subtypes. The 
structures obtained were investigated visually with regard to their ligand-protein-
interaction within PyMOL 1.3 (PyMOL, 2014). Structural features of the ligands, 
particularly when apparently responsible for similar ligand-protein-interactions, were 
extracted. These structural features were coded manually into SMARTS strings. 
Subsequently the SMARTS strings were used within a rule-based workflow to test the 
predictive potential toward NR ligands. 
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6.2.2. Analysis of physico-chemical properties 
Similar to Chapter 5, ligands for all subtypes of LXR, PPAR, RAR/RXR and FXR were 
compiled from the ChEMBL database (ChEMBL, 2014). Their pChEMBL values were 
used as a means to order activity. Only chemicals with a pChEMBL values > 5 were 
considered as being active. CDK's molecular properties node was used to calculate all 
relevant descriptors within KNIME (KNIME, 2014): MW for molecular size, VAIM and 
eccentric connectivity index (ECI) for structural complexity, RB for molecular flexibility 
and topological polar surface area (TPSA) and XLogP for hydro- and lipophilicity 
respectively. 
  
6.3. Results 
The investigation of physico-chemical properties of the ChEMBL ligands and the 
analysis of the protein-ligand interaction of the PDB data resulted in the information 
presented below. Further details, such as activity data, SMARTS strings and the rules for 
the incorporation of SMARTS strings and property ranges within a screening tool 
(relevant for writing codes / rebuilding the workflow) are presented in appendix A.5 and 
B.3. 
 
6.3.1. RAR/RXR 
After observing the RAR and RXR receptors separately it was noted that their actives had 
very similar binding patterns and it was decided to combine them into one workflow. A 
total of 958 RAR actives and 1188 RXR actives were extracted from the ChEMBL 
database. 20 human RAR structures bound to different ligands were retrieved from the 
PDB. The RXR had a further 64 different human protein structures within the PDB. 
 
Identification of nuclear receptor ligands associated with hepatotoxicity 
88 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1: Ligand-protein-interaction of the γ-RAR (2LBD) indicating hydrogen bonds of       
retinoic acid within the receptor pocket (PDB, 2015) 
 
The information obtained from observing RAR/RXR ligand-protein-interactions, as well 
as common substructures and physico-chemical properties were combined to form a rule-
based screening workflow. The physico-chemical properties of the RAR/RXR actives 
were observed and the ranges that chemicals must fall within to be active were defined. 
The physico-chemical properties selected were MW, VAIM, RB and XLogP. It can be 
concluded that RAR/RXR ligands have a generally flexible, lipophilic and mostly 
aliphatic scaffold in common, as described in Table 6.2. 
 
Table 6.2: Physico-chemical property ranges for RAR/RXR actives 
Physico-chemical property Value 
MW ≤ 550 
VAIM 5 - 7 
RB 3 - 30 
XLogP 2.2* - 20 
* with 3 outliers < 2.2 (refer to RAR/RXR rules in Appendix B.3)  
 
The rules in Table 6.2 can be similarly interpreted to Chapter 5’s Table 5.2. In other 
words, the values and ranges of Table 6.2 can be seen as single and double cut-offs for 
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each property. Generally RAR/RXR ligands are lipophilic, however there are a small 
number of compounds which are active without being lipophilic (XLogP < 2.2), e.g. n-
phosphono-L-phenylalanyl-L alanylglycinamide with an XLogP of -2.4. As these 
compounds have peptide-like bonds, XLogP exception rules were created. To narrow 
down the compounds passing through this physico-chemical filter, such as inactive amino 
sugars, a further filter was used. As shown in Figure 6.1, there are certain groups in the 
ligand (in particular double-bond oxygens), binding to one or two arginine residuals of 
the receptor, e.g. the hydrogen bond between arginine R278 and an oxygen of a ligand’s 
carboxylic group within the RAR domain. In addition, serine S289 seems to support this 
functional group with another hydrogen bond (refer to Fig. 6.1). The responsible 
structural features are described in a structural alert system. Furthermore, RAR/RXR 
ligands contain at least one ring structure, which could be aromatic or aliphatic, e.g. 
cyclohexene of retinoic acid, as expressed in the structural alert system (refer to 
Appendix B.3) (PDB, 2015; Klaholz et al., 2000; Steinmetz et al., 2015a). 
 
6.3.2. PPAR 
A total of 8548 PPAR actives were extracted from the ChEMBL database. The following 
summarises the ligand-binding interactions of the PPAR actives observed within the PDB. 
In total 175 human PPAR structures were found. 
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Figure 6.2: Ligand-protein-interaction of the γ-PPAR (4O8F) indicating hydrogen bonds with the 
polar ring system of a ligand and amino acid residues (PDB, 2015) 
 
 
The information obtained from observing PPAR ligand-protein-interactions, common 
substructures and physico-chemical properties were combined to form a rule-based 
screening workflow. The physico-chemical properties of the PPAR actives were observed 
and ranges that chemicals must fall within to be active were defined (Table 6.3). The 
physico-chemical properties chosen as filters were MW, VAIM, TPSA and XLogP. 
 
Table 6.3: Physico-chemical property ranges for PPAR actives 
Physico-chemical property Value 
MW ≤ 800 
VAIM 5 - 7 
TPSA 20 - 300 
XLogP 1.2 - 20 
 
PPAR actives were studied and the substructural features relevant to activity were coded 
into SMARTS (as described in Appendix B.3). As none of the 8548 actives has a steroid-
typical tricyclic backbone, which is in itself rather unusual for most NR ligands, an 
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exclusion filter was created, i.e. the chemical of interest must not contain a steroid 
backbone to be classified as active. Further, the compound must contain one of the 
specific “diaromatic” scaffolds and one of the specific functional groups, which arise 
from hydrogen bonds to relevant amino acid residues (mainly from tyrosine, serine or 
histidine), in order to be classified as an active (refer to Fig. 6.2). An additional alert 
system describing fatty acid- and retinoid-like compounds (similar to RAR/RXR), 
indicates moderate PPAR affinity so triggers an alert (refer to Appendix B.3). This 
extension of the PPAR workflow is similar to the RAR/RXR workflow, i.e. it is searching 
for an identifying for mostly aliphatic, flexible chains with terminal polar groups 
(preferably carboxylic groups). Only one PPAR ligand from ChEMBL with a low activity 
(pChEMBL = 6.09) was not identified. 
6.3.3. LXR 
A total of 1721 LXR actives were extracted from the ChEMBL database. The following 
summarises the ligand-binding interactions of the LXR actives observed within the 16 
human structures found within the PDB (PDB, 2015).  
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Figure 6.3: Ligand-protein-interaction of the β-LXR (4NQA) indicating hydrogen bonds and π-
system-interactions as relevant for receptor binding (PDB, 2015) 
 
The information obtained from observing LXR ligand-protein-interactions, common 
substructures and physico-chemical properties were combined to form a rule-based 
screening workflow. The physico-chemical properties of the LXR actives were observed 
and ranges that chemicals must fall within to be active were defined (Table 6.4). The 
physico-chemical properties chosen as filters were MW, VAIM and XLogP and TSPA. 
 
Table 6.4: Physico-chemical property ranges for LXR actives 
Physico-chemical property Range 
MW ≤ 750 
VAIM 4.7 - 7 
TPSA 5 - 150 
XLogP ≥ 2 
 
LXR actives were studied and the substructural features were coded into SMARTS (refer 
to Appendix B.3). A potential ligand contains ring backbones, which have certain 
interactions with arginine residues or secondary amine of leucine, particularly with a 
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carboxylic group, aromatic methoxy groups and other “terminal” oxygens (refer to PDB, 
2015: 3LOE, 4NQA, 4DK7). On the halogenated, particularly fluorinated, side of the 
ligand there might be interactions with histidine as well as shown in protein-ligand-
structure 3FAL (H419). Additionally, π-stacking and similar interactions of the ligand’s 
aromatic rings to phenylalanine and tryptophan residues may be relevant for the ligand-
receptor-binding. An example ligand, mostly known as GW-3965, binding to β-LXR is 
presented in Figure 6.3. 
 
6.3.4. FXR 
Although FXR agonists are not associated with NASH directly, their contribution 
towards cholestasis etc. makes them worth identifying. Hence, a total of 26 human FXR 
structures were found in the PDB and further 715 active ligands where retrieved from 
ChEMBL.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4: Ligand-protein-interaction of the FXR (3HC5) indicating hydrogen bonds on two 
ends of a lipophilic “tunnel” (PDB, 2015) 
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The information obtained from observing FXR ligand-protein-interactions, common 
substructures and physico-chemical properties were combined to form a rule-based 
screening workflow. The physico-chemical properties of the FXR actives were observed 
and ranges that chemicals must fall within to be active were defined (Table 6.5). The 
physico-chemical properties chosen as filters were MW, ECI, RB and TPSA. 
 
Table 6.5: Physico-chemical property ranges for FXR actives 
Physico-chemical property Range 
MW ≤ 900 
ECI 150 - 2400 
RB ≥ 2 
TPSA 15 - 200 
 
Different active ligands of the FXR were investigated (refer to PDB, 2015: 4WVD 
(former 4II6), 3HC5, 4QE6) and structural features relevant regarding shape and 
functionality, in particular formation of hydrogen bonds, were coded in SMARTS (refer 
to Appendix B.3). Beside the fit of the molecule within the lipophilic “tunnel”, which is 
determined by residues of leucine, isoleucine etc., hydrogen bonds to polar residues of 
amino acids, such as serine, tyrosine, histidine and arginine, seem to be important for 
binding. Both interactions are depicted in Figure 6.5, where a synthetic ligand binds 
within the receptor pocket. Natural ligands are often steroid compounds, e.g. 
chenodeoxycholic acid (refer to bile salts). 11 of the 715 compounds from ChEMBL did 
not pass the identification criteria of the FXR-workflow. However, these outliers had 
only low activity (pChEMBL ≤ 5.56), such as clotrimazole, an antifungal pharmaceutical, 
and JHW-015, a synthetic cannabinoid – both with a pChEMBL value of 5.49. 
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6.4. Discussion 
The results from within Chapter 6, i.e. the classification rules for each NR, can be used to 
build a workflow to identify potential receptor binders (as achieved in Chapter 5). The 
information/codes necessary for this type of workflow are gathered in Appendix B.3. The 
workflow based on these rules is then able to identify compounds potentially acting as 
NR ligands, i.e. RAR/RXR, PPAR, LXR and FXR ligands respectively. As potential NR 
ligands are likely to trigger a MIE associated with toxic effects, such as hepatosteatosis or 
cholesatasis, this information is highly relevant for risk assessment within an AOP or 
read-across concept (Vinken, 2013; Schultz et al., 2015; Patlewicz et al., 2014). 
The predictive power of the workflow is difficult to measure as there are no 
test/validation data available. As the SMARTS strings and rules are created manually all 
data need to be considered as “training data”. Without approaches such as cross-
validation or bootstrapping, it is impossible to express statistical performance. However, 
what can be observed is that the training data, the ChEMBL datasets, were all identified 
by the rules, except one PPAR and eleven FXR ligands with low activity (pChEMBL ≤ 
6.09). In other words, only twelve out of 13130 actives were not assigned correctly. This 
indicates a certain degree of sensitivity, but it is likely that specificity is only moderate to 
low, i.e. false positives are likely. To confirm suggested activity, it is recommended to 
support the NR-workflow results with additional in vitro assays and/or further in silico 
tests, e.g. docking, QSAR models. 
The concept described here (and in Chapter 5) can be extended to many other receptor-
mediated toxicity endpoints and so support regulatory toxicology and, thus, tasks such as 
risk and safety assessment. Of course, specificity of such a model is always dependent on 
the actual content of databases, e.g. ChEMBL and PDB. Further it must be noted that 
other hepatosteatosis and cholestasis pathways exist, for example via mitochondrial 
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toxicity (Patel and Sanyal, 2013), i.e. this concept cannot to be extended to cover all 
relevant MIEs for hepatosteatosis and cholestasis. On the other hand “ligands for NRs” is 
an important class of toxicants.  
Regarding the FXR, a recent illustration of an AOP for the bile salt export pump (BSEP) 
has been described which states how FXR agonists may significantly induce cholestasis 
and jaundice (Vinken, 2015). However, with regard to FXR’s role in lipid homeostasis, it 
is still unclear whether FXR ligands promote hepatosteatosis (refer to Moya et al., 2010). 
Liu et al. (2014b) have actually postulated that the agonist may counteract hepatosteatotic 
effects. This leads to the question of whether FXR antagonists may trigger 
hepatosteatosis. In particular, as the screening workflows developed within this thesis are 
not likely to differentiate between competitive agonists and antagonists (refer to Chapter 
5). Nevertheless it could be worth screening for FXR ligands with regard to 
hepatosteatosis. It must also be pointed out that adverse effects which expand onto a 
histopathological level, e.g. fibrosis, steatosis, cholestasis, may contribute to similar 
clinical symptoms and manifestations. 
Even if this thesis is more focussed on deriving knowledge from hepatotoxic AOPs, it 
should be emphasised that adverse effects of NR ligands are not only restricted to 
hepatotoxicity. Beside clinical pharmacology and toxicology, the identification of NR 
ligands and prediction of their potential targets is of great interest for ecotoxicology and 
environmental health as well, e.g. the identification of endocrine disruptors in wastewater. 
In modern risk assessment, particularly when avoiding animal testing, it is important to 
use synergies from these different disciplines. 
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6.5. Conclusions 
Identification of AOPs and MIEs is a growing topic in many sub-disciplines of 
toxicology, e.g. regulatory toxicology and risk assessment. NR ligands trigger 
toxicological effects such as hepatosteatosis and NASH respectively. A workflow 
predicting NR-associated hepatotoxicity (predominately hepatosteatosis) has been 
developed. Combined with further NR-workflows (e.g. glucocorticoid, oestrogen and 
vitamin D receptor) the workflow is available in COSMOS Space, a user interface hosted 
by the COSMOS project (Mellor et al., 2015; COSMOS, 2015). A screenshot of the 
principle design of a screening KNIME workflow is shown in Chapter 5 (Fig 5.3) and a 
summary of rules (including SMARTS strings) is presented in Appendix B.3. 
This chapter extends the results of Chapter 5, but it is also an excerpt of Mellor et al. 
(2015), which deals with additional NRs. While many computational toxicology tools 
focus on reactivity (e.g. Enoch et al., 2011), receptor-mediated toxicity is an essential 
addition in the greater picture of toxicology and risk assessment. This shows the 
relevance of this work for the COSMOS project and for non-testing approaches (e.g. 
read-across) in the regulatory context. 
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7. In silico prediction of liver toxicity: The development of novel 
structural alerts* 
7.1. Introduction 
Liver toxicity is an important endpoint for human toxicology in general. The liver plays 
an important role in many metabolic pathways, for example, in the digestion of food or 
the clearing and transforming of xenobiotics. The organ is well perfused, with arterial and 
(portal) venous blood. Damage of the liver can result to liver failure and even cause death 
(Chen et al., 2011). There are different types of pathologies of the liver that can be 
promoted by chemical insult, such as inflammation, fibrosis, steatosis, cholestasis and 
cancer (Fourches et al., 2010; Hewitt et al., 2013; Przybylak and Cronin, 2012). MIEs 
relevant for hepatosteatosis and cholestasis are discussed in Chapter 6. Particularly 
relevant for hepatotoxicity are compounds taken orally (e.g. via food, drugs etc.) that may 
enter the liver after passing through the gastro-intestinal tract. If compounds, so absorbed, 
are potentially toxic, e.g. inducing mitochondrial toxicity, the liver is often the first organ 
to suffer from their potential adversity (Mennecozzi et al., 2012). Furthermore metabolic 
activation of compounds to more toxic forms might take place in the liver that leading to 
subsequent toxic effects, particularly occurring in adjacent organelles, cells and tissues 
(Barile, 2004; Rang et al., 2007a). Systemically available compounds which have not 
been altered metabolically (for example by the first-pass effect) can also damage the liver. 
They will pass through the liver at high volume and may continuously harm the liver via 
the systemic circulation. Chronic exposure of toxicants may also manifest in a substance-
induced liver injury. As cosmetic ingredients are often intended to be applied regularly, 
safety assessment must encompass hepatotoxicity as well. This is the rationale behind 
SEURAT-1’s focus on finding alternative testing methods to identify hepatotoxicity,  that 
* This chapter is an extension of the work of Hewitt et al. (2013) 
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could otherwise only be identified in animal intensive (sub)chronic assays (Yamada et al., 
2013; Tralau et al., 2015). 
Besides in vitro and in vivo data dealing with mechanisms and pathologies of liver 
toxicants, human liver toxicity data are rare and of poor quality respectively. In particular 
chronic hepatotoxicity studies are mostly based on pharmacovigilance and other 
epidemiological studies, for example the harvesting of clinical literature data by Fourches 
et al. (2010) and Chen et al. (2011). Regarding pharmacovigilance data, it must be 
stressed, that adverse effects to the liver are a leading cause of pharmaceuticals failing 
during clinical trials and being withdrawn from the market. These adverse effects may 
vary in severity and type of liver injury, e.g. steatosis, cholestasis or acute liver failure 
(Chen et al., 2011). As liver injury is not exclusively relevant to pharmaceuticals, 
methods to identify liver toxicants (e.g. structural alerts) may be used for the risk 
assessment of other classes of compounds, for example, cosmetics, food additives. 
Prediction of liver toxicity may be interpreted differently according to the respective field. 
For example in the clinical environment biomarkers, such as elevated aminotransferases 
or bilirubin (refer to jaundice) or the decrease of specific proteins (e.g. kallistatin), are 
used as indicators for liver toxicity (Cheng et al., 2015b; Przybylak and Cronin, 2012). 
However, these biomarkers are associated with existing liver injury; hence they play an 
important role in clinical liver function tests. The question rises to what extent these 
biomarkers can be used in in vitro assays and if they could be applied to the entirety of 
hepatotoxic mechanisms. In practice, there is no single in vitro hepatotoxicity assay, but 
there are assays for different modes of action / mechanisms, e.g. mitochondrial 
dysfunction, protein adduct formation (Mennecozzi et al., 2012). This scenario is similar 
for in silico approaches for hepatotoxicity in the context of predictive toxicology (refer to 
Chapter 1). Generalised computational hepatotoxicity models do not work sufficiently 
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and further they do not differentiate mechanisms in a transparent way. Nevertheless, there 
are promising models within mechanistic categories (i.e. groups of similarly acting 
compounds). This is a strong argument for the development of tools to identify 
mechanisms and MIEs respectively (as undertaken in Chapter 5 and 6). Additionally it 
should be pointed out that there are further factors, such as polymorphism and 
environmental factors, which impede the creation of computational models (Przybylak 
and Cronin, 2012). 
Hewitt and colleagues (2013) defined structural alerts for liver toxicity based on 
structural similarity of pharmaceutical liver toxicants of the Fourches et al. (2010) 
database. They defined 16 structural alerts (glucocorticoid steroids, nitrogen mustards, 
catechols etc.) and investigated the mechanisms through an intensive literature research. 
In this study additional structural alerts were created from the investigation of the Chen 
database (Chen et al., 2011). A comparison of the Fourches and Chen databases is shown 
in Table 7.1. Here it must be noted that a binary system (hepatotoxic and non-hepatotoxic) 
was used by Fourches, however a ternary system of classification was used by Chen. 
Hence, this does not allow for an exact comparison of the statistics. However, compounds 
of both datasets can be compared and investigated on a structural level. Structural alerts, 
for example, are a way to capture substructures (and related structural information) and 
further to screen compounds of interest for these substructural features. The structural 
alerts were coded in SMARTS strings (Daylight, 2014; Sushko et al., 2012). The aim of 
this chapter was to create new structural alerts for liver toxicity (complementing the 
already existing Hewitt alerts) and so build a “finer mesh” to screen compounds for the 
potential substance-induced liver injury. Furthermore this work suggests a way to 
progress with structural alerts in general, i.e. first using already identified structural alerts 
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on a new database to check validity and second, identifying new structures for potential 
adverse effects. 
Table 7.1: Comparison of the liver toxicity databases of Fourches and Chen 
 Fourches et al. (2010) Chen et al. (2011) 
Origin of data Literature research Literature research 
Applicability Human, pharmaceutical Human, pharmaceutical 
Number of 
compounds 
951 287 
Hepatotoxic 
categories 
2 (0,1) 
0 being no hepatotoxic concern 
1 being high hepatotoxic concern 
 
3 (0,1,2) 
0 being no hepatotoxic concern 
1 being low hepatotoxic concern 
2 being high hepatotoxic concern 
1 (n = 650) 0 (n = 301) 2 (n = 137) 1 (n = 85) 0 (n = 65) 
 
7.2. Methods 
7.2.1. Data collection and curation 
The Chen et al. (2011) dataset contains information on 278 pharmaceuticals including 
descriptions of potential hepatotoxicity (refer to Table 7.1). This information describes on 
the severity based on the actual adverse effects, and in addition to the concern based on 
pharmacovigilance data, i.e. incorporating statistical evidence and severity – similar to 
the work of Fourches et al. (2010), it is derived from the scientific literature. SMILES 
strings for each compound were taken from Chemspider (RSC, 2014). After screening all 
278 structures with the 16 structural alerts of Hewitt et al. (2013) with KNIME (refer to 
section 7.2.4), the hepatotoxic compounds, which have not been classified as such (i.e. 
false negatives), were investigated for molecular similarity. 
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7.2.2. Molecular similarity 
To identify new categories of structurally similar compounds of the false negative 
hepatotoxicant from section 7.2.1, the freeware Toxmatch v1.07 (IDEAconsult, 2014b) 
was used. While the compounds have been tested against each other for atom 
environment similarity, the similarity matches were defined as being greater than or equal 
60%. Compounds with multiple matches have been extracted from the dataset to 
investigate common substructures and scaffolds. 
7.2.3. Creating structural alerts for liver toxicity  
After the structures were investigated regarding their similarity, they were 
visually/manually grouped based on common structural features. After the grouping 
process, novel structural alerts were created by embedding relevant structural information 
into code. The novel structural alerts were coded in SMARTS strings, so they can be used 
to identify unknown compounds of the same category. The purpose of the new structural 
alerts is to complement the Hewitt et al. (2013) alerts, as the correctly identified 
hepatotoxic compounds (true positives) were not considered. In other words, this study 
focusses on the hepatotoxicants, which cannot be identified by Hewitt et al. (2013) alerts 
alone. 
7.2.4. Screening and validation of structural alerts  
The screening itself (employing the respective structural alerts) was done within KNIME 
2.7.2 (KNIME, 2014) using the Indigo substructure matcher. The screening performance 
of the Hewitt et al. (2013) alerts and of a combination of the Hewitt et al. (2013) and the 
novel alerts was investigated using the Chen et al. (2011) and the Fourches et al. (2010) 
datasets. For the novel structural alerts, the Chen et al. (2011) dataset can regarded as 
training dataset and the Fourches et al. (2010) dataset can be regarded as validation 
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dataset. However it must be stressed that there is a large overlap of compounds in both 
datasets and even some with conflicting information on hepatotoxicity. 
7.3. Results and discussion 
The Chen et al. (2011) dataset holds 196 compounds of moderate to high 
hepatotoxicological concern, which were not identified by the Hewitt et al. (2013) alerts. 
Based on the outcome of the structural similarity analysis with Toxmatch, ten novel 
structural alerts (presented as SMARTS strings in Table 7.2). Each of the substructures 
describes a group of compounds with a potential for hepatotoxicicity. 
 
Table 7.2: Ten novel structural alerts for liver toxicityx 
1 *[N*,nH,NH]S(*)(=O)=O 
 
2 [*]C(=O)Nc1ccccn1 
 
3 [*]c1oc2ccccc2c1C([*])=O 
  
4 [N,C][N,C]1c2ccccc2CCc2ccccc12 
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5 C[NH1][NH2,NH1] 
 
6 c1ccc2[n,c]cccc2c1 
 
7 Nc1nc2n(CO*)cnc2c(=O)[nH]1 
 
8 O=C1CC2CCC3C4CCCC4CCC3C2C[O,C]1 
 
9 O=C1NC=NN1CCCN1CCN(CC1)c1ccccc1 
 
10 S=C1N=CNc2[n]cnc12 
  
xa complete list of the combined 26 hepatotoxicity alerts (Hewitt et al. and Steinmetz) is attached 
to Appendix B.1  
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The principle idea of the creation of the novel structural alerts from this analysis (refer to 
Table 7.2) was to combine them with the 16 structural alerts of Hewitt et al. (2013). In 
the Chen et al. (2011) database the Hewitt et al. (2013) structural alerts identified 14 of 
137 compounds with high hepatotoxic concern, 12 of 85 compounds with low 
hepatotoxic concern and 4 of 65 compounds with no hepatotoxic potential. Combining 
the Hewitt et al. (2013) alerts with the novel alerts of Table 7.2 led to the identification of 
43 of 137 compounds with high hepatotoxic potential, 27 of 58 low hepatotoxic concern 
and 5 of 60 no hepatotoxic concern. So while increasing the identification of compounds 
with high hepatotoxic potential by 21.2%, the incidence of false positives (no hepatotoxic 
concern) has only been increased by 1.5 % (refer to Table 7.3). 
When applying the same comparison to the Fourches database as a test set, similar 
differences can be seen. The combined 26 alerts identified 169 of 650 compounds with 
high hepatotoxic potential, whereas the Hewitt et al. (2010) alerts on their own only 
identified 108 of 650 compounds with high hepatotoxic potential. This means nearly 9.4% 
more potentially hepatotoxic compounds have been identified with the combined 26 
alerts. On the other hand, the number of false positives increased from 41 to 56 from a 
total of 301 non-hepatotoxic compounds. This is an increase of false positives of 5.0% 
(refer to Table 7.4). 
 
Table 7.3: 16 and 26 structural alerts tested on Chen et al. (2011) database 
Using 16 Alerts (Hewitt et al., 2013) 
 
 Using 26 Alerts (combined) 
Hepatotoxic 
category 
Match No match Total 
 Hepatotoxic 
category 
Match No match Total 
2 14 123 137  2 43 94 137 
1 12 73 85  1 27 58 85 
0 4 61 65  0 5 60 65 
Total 30 257 287  Total 75 212 287 
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Table 7.4: 16 and 26 structural alerts tested on Fourches et al. (2010) database 
Using 16 Alerts (Hewitt et al., 2013) 
 
 Using 26 Alerts (combined) 
Hepatotoxic 
category 
Match No match Total 
 Hepatotoxic 
category 
Match No match Total 
1 108 542 650  1 169 481 650 
0 41 260 301  0 56 245 301 
Total 149 802 951  Total 225 726 951 
 
The hepatotoxic categories from Table 7.1 express hepatotoxic concern, i.e. there are the 
binary Fourches (0,1) and the ternary Chen (0,1,2) dataset. The Fourches and the Chen 
datasets have an overlap of 107 compounds. The majority of the compounds defined as 
hepatotoxic by Chen (1,2) are hepatotoxic by Fourches as well (1) and vice versa. One 
exception would be the vasodilator benziodarone (Chen: 2), which was classified by 
Fourches as non-hepatotoxic (0). Conversely there are exceptions, such as the 
anticonvulsant pyrimidinedione primidone (Chen: 0) or the sugar alcohol D-(-)-mannitol 
(Chen: 0), which are both classified as hepatotoxic by Fourches (1). 
As hepatotoxicity is such a complex, multifactorial phenomenon, it is difficult to improve 
performance of screening models based on structural alerts. Different pathways relevant 
for metabolic activation or deactivation, different genetic heritages leading to enzymatic 
polymorphism and different environmental factors, such as beverages, foods, drugs etc., 
play an important role in the manifestation of liver toxicity. Of course a screening tool 
raising alerts might be useful for drug development, but gaining knowledge of the exact 
mechanisms and kinetics relevant for histopathologies associated with hepatotoxicity is 
of greater importance (Przybylak and Cronin, 2012; Chen et al., 2011).  
 
7.4. Conclusions and perspectives 
Identifying compounds which are likely to be liver toxicants is crucial in drug design but 
also convenient in other areas such as safety and risk assessment. Defining more 
structural alerts for liver toxicity could be beneficial for many areas; from occupational 
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health to assessing consumer products, e.g. cosmetics. The development of the novel 
structural alerts within this work led to the identification of 61 more potential liver 
toxicants from the databases, with only a very small increase in false positives (15), 
within the Fourches dataset (refer to Table 7.4). 
Principally the approach of this work is that it can be repeated with every new 
pharmacovigilance liver toxicity dataset, and every time new structural alerts would be 
created. Over time this could lead to a “finer mesh” of alerts (or a “tighter sieve”) 
enabling the screening of a wide range of chemical compounds for substance-induced 
liver injury. Future work may also include the refinement of alerts, for example the 
steroid alerts of Hewitt et al. (2013), which do not identify all hepatotoxic steroids of 
Chen et al. (2011). As this work proposes another steroid alert (refer to SMARTS string 
no. 8 in Table 7.2), it is an interesting question if a simpler, broader steroid alert might be 
of more value, particular for the alerts’ predictive power.  
As liver toxicity is a complex phenomenon, which can be triggered by many different 
mechanisms (Mennecozzi et al., 2012), it is unlikely that liver toxicity could be 
determined by structural alerts alone – at least not as an accurate predictive tool. 
Particularly as the absence of an alert does not make a compound non-toxic (Przybylak 
and Cronin, 2012), there would be a danger of combining structural alerts to increase 
sensitivity until specificity is lost (and false positives become rather rule than exception).  
Beside the refined methodology, the current structural alerts combined with the 16 liver 
toxicity alerts of Hewitt et al. (2013), as summarised in Appendix B.1, are a tool able to 
support current non-testing approaches and in silico risk assessment. However, it must be 
pointed out that they represent only a small excerpt of potential hepatotoxicants. The 
approach, even while using highly relevant data, is less mechanistically driven than the  
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approach in Chapter 5 and 6. However, in the context of the AOP framework and the 
usage of the methods suggested in Chapter 5 and 6, results could become more refined – 
particularly when considering the relevance of clinical/pharmacovigilance data to today’s 
risk assessment approaches.  
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8. Discussion 
8.1. Summary of work 
The assessment of the risk following exposure to any chemical, and hence its safety, is a 
non-trivial task and dependent on various types of information such as exposure, 
toxicokinetics and mode of action (MoA). When dealing with untested compounds, 
predictions based on data for tested compounds have to be made. This is usually 
performed with predictive toxicology tools, e.g. QSAR models or read-across. One 
problem with these approaches is that they are highly dependent on the data quality of 
already tested compounds. In Chapters 2 and 3 it has been demonstrated that existing, 
historical biological data are often of poor or unknown quality. Confidence in the use of 
such data can only be achieved by repetition of tests by independent researchers, with 
examples provided from the areas of skin penetration and aquatic toxicology where many 
historical data are available (Steinmetz et al., 2014; Steinmetz et al., 2015b). Similar 
problems regarding irreproducibility were investigated by Gottmann and colleagues 
(2001) who, following an investigation of carcinogenicity data, concluded that two large 
rodent datasets were only 57% concordant. The differences in bioassay results were not 
explainable by sex, species, strain or target organ. The problems with data quality raises 
the question of how many predictive toxicology models and expert systems are based on 
reliable data and assumptions of data, and how they might change when only high quality 
data are used. One reason for this lack of knowledge is that it is difficult to determine the 
impact on existing models since there are few duplicate experimental data; this is because 
it is usually considered as a waste of money and resources, in addition to the issues 
relating to ethics, to re-test substances. It should also be recognised that further technical 
replicates are not likely to be the key to solve this problem, as most sources of error 
cannot  be  excluded  by  immediately/simultaneously repeating  an assay  with  the  same  
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sample, reagent, apparatus, staff etc. (Madden et al., 2012). Generally accuracy and 
precision of experimental values are important factors associated with repeatability and 
experimental error. On the one hand, consistency in the execution of experiments, for 
example by the usage of standard operating procedures (SOPs), can lower experimental 
errors. On the other hand, biological data are dependent of too many variables to address 
issues with accuracy and precision properly. These circumstances lead to a general 
uncertainty of biological data. One solution is to apply the confidence score (CS) within 
QSAR modelling, development of structural alerts, read-across or validation approaches 
to improve predictive toxicology. Even if the rebuilding and renewing of well used 
models incorporating more reliable data and/or confidence (as presented in this thesis) 
improves models only slightly, ultimately they provide a more realistic (weight of) 
evidence-based approach, as demanded by the users of predictive toxicology tools. In the 
long run, being able to assess the uncertainty of data could enable a measure of 
confidence to be assigned to predictions from QSAR models etc. For instance, greater 
confidence could be achieved by focusing model development and validation on the most 
reliable data points (for example applying the methods described in Chapters 2 and 3). 
The assessment of data quality is obviously vital for their use in risk assessment and 
modelling. However, data quality is not the only criterion required to perform risk 
assessment; it is essential to obtain information on exposure, kinetics and, if available, 
MoA as well. With regard to cosmetic ingredients in particular, knowledge of skin 
permeability and dermal absorption is crucial. Whilst skin permeability only describes the 
passage of a molecule through the uppermost skin layers, such as the stratum corneum, 
dermal absorption data describe the complete process from the dermal administration of a 
compound to its detection in the blood. Whereas data for skin permeability have the 
advantage that they can be generated using an in vitro assay (using, for instance, human 
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skin), the investigation of dermal absorption is typically dependent on in vivo tests. It 
must be remembered that dermal metabolic activity is neglected in skin permeability tests 
as opposed to dermal absorption tests, as in rare cases results and conclusions may differ. 
In addition the dermal absorption of chemicals by rodents is likely to be higher than for 
humans due to their higher pore density (simply due to rodents having fur) compared to 
human skin. Even if animal tests on cosmetic ingredients are not allowed anymore, this 
must be factored into in silico predictions employing in vivo data (Mitragotri et al., 2011; 
Ravenzwaay and Leibold, 2004; Hughes and Edwards, 2010). 
Regardless of the data type indicating dermal absorption, without systemic availability it 
is unlikely for a substance to reveal systemic toxic effects. The skin permeability of a 
compound is determined by many factors such as its concentration, volatility, effect of 
the formulation or delivery vehicle and the substance-specific kp value. This kp value is 
one of the key (physico-)chemistry-dependent properties reliant on molecular size and 
lipophilicity (Potts and Guy, 1992; Mitragotri et al., 2011). A validated, robust QSPR 
model to predict the kp value of an untested compound is reported in Chapter 3 (Eq. 3.5). 
Dermal absorption, similar to oral bioavailability, is dependent on a compound’s physico-
chemical properties. The principle concept is that small, moderately lipophilic (i.e. 
uncharged) compounds pass through relevant membranes more easily than ionic or large 
compounds (Lipinski et al., 2001; Mitragotri et al., 2011). Based on the same scientific 
background, a rule-based prediction system has been built to classify dermal absorption 
of hair dyes (refer to Chapter 4). The rules are based on the same idea of small, 
moderately lipophilic compounds passing through relevant membranes. Beside MW and 
log P, information on MP and TPSA improved the performance of the rule-based 
prediction models. Many hair dyes are known for being toxic, for example due to protein 
and DNA binding. This indicates a principle hazard for mutagenicity and eventually 
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carcinogenicity (Vinardell et al, 2015; Nelms et al., 2015). It is important for consumers 
not to absorb these compounds in quantities where they might cause systemic toxicity, e.g. 
geno-, hepato- or nephrotoxicity. Regarding risk assessment, it is assumed that low 
dermal availability is a key factor for safety. Both methods, the QSPR model (refer to 
Chapter 3) and the rule-based prediction system (refer to Chapter 4), can support risk 
assessment of cosmetic ingredient regarding their dermal and systemic availability. 
Whilst the QSPR is designed for a broad applicability domain of organic chemicals, the 
rule-based prediction system is designed for hair-dyes and associated substances. Another 
big difference is that the QSPR model calculates continuous data points, i.e. absolute kp 
values, the rule-based prediction system orders compounds into two classes according to 
an internally decided safety threshold for hair dyes and associated substances. 
As well as kinetics, MoA and, in particular, MIEs are of great interest for predictive 
toxicologists. As MIEs represent the initial chemical interaction of a chemical compound 
with a biological target (e.g. protein), every toxicological effect is based on at least one 
MIE. Predictive toxicology tries to associate chemical information with adverse effects, 
hence the prediction of initial chemical interactions is probably the most obvious 
approach to this field. This thesis (and also the COSMOS Project and indeed the 
SEURAT-1 Cluster) has had a clear focus on hepatotoxicity. As a typical pathology 
caused by chronic, systemic toxicity, adverse effects to the liver are relevant for 
consumer goods including cosmetic products (Tralau et al., 2015; Vinardell, 2015). Many 
different mechanisms are known to cause hepatotoxicity however, with regard to 
cosmetic ingredients, there is great interest, and indeed need, to identify compounds with 
the ability to cause adverse effects at low doses and following repeated exposure. 
Amongst other mechanisms, NR ligands play an important role in liver toxicity. Since 
many NR ligands have the potential to trigger cholestasis and hepatosteatosis (Vinken, 
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2015; Mellor et al., 2015). An in silico method to screen for potential agonists has been 
developed and described in Chapter 5 (Steinmetz et al., 2015a). This methodology, which 
employs calculated physico-chemical properties and combinations of structural features, 
was extended in Chapter 6 to be applicable to more NRs (Mellor et al., 2015). The in 
silico screening tools described in Chapters 5 and 6 are developed by using in vitro 
datasets, i.e. clinical relevance for every prediction cannot be assured to the same extent 
as for models exclusively based on in vivo data. It must be noted that in vitro and in vivo 
data always embody limitations towards the prediction of clinical outcomes, and that 
even clinical data are not always suitable (refer to polymorphism). Nevertheless, the in 
silico screening tools built within this thesis can be used for the generation of new leads 
in drug design and as a tool in risk assessment (e.g. for category formation) due to their 
conservative and generalistic nature of the model. Additionally prioritisation, for example 
in ecotoxicology, to identify hazardous agents would be another application for the 
screening tool. 
The results described in Chapter 7 are more clinically relevant as they address clinical 
(pharmacovigilance) data from Fourches et al. (2010) and Chen et al. (2011). It must be 
pointed out that cosmetic ingredients should generally (with a few exceptions) not have 
any clinical relevance, i.e. pharmacological/toxicological effects. The liver toxicity data 
have been used to create structural alerts to identify potential hepatotoxicants. The work 
described in Chapter 7 is principally an extension of the approach taken by Hewitt et al. 
(2013), who presented a comprehensive review on mechanisms of liver toxicity and 
assigned a small number of structural alerts to these mechanisms. The focus of this study 
was not to extend the review but develop further structural alerts for hepatotoxicity. The 
structural alerts defined in Chapter 7 represent substructures associated with 
hepatotoxicity under chronic administration; ten new alerts have been added to the 
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existing sixteen of Hewitt et al. (2013). Since the in silico screening tools (refer to 
Chapters 5 and 6) predict only the potential to elicit a MIE, they do not predict 
toxicological effect directly. Whereas the structural alerts of Chapter 7 predict clinical 
toxicity directly. Even if the answers of the structural alerts model seem to be more 
relevant, it must be noted that the data were very limited regarding structural diversity 
and data quality. Practically this means, that the combined structural alerts of Steinmetz 
and Hewitt together do not capture the entirety of hepatotoxicants. However, as shown in 
Chapter 7, the extension enables to identify many more hepatotoxicants without 
compromising integrity. All workflows and codes needed to build the described screening 
tools are attached in Appendices. 
This thesis provides a number of different approaches relevant to risk assessment, e.g. 
models for hazard identification and exposure, so consideration is required as to how this 
body of work contributes to the toxicological assessment of novel cosmetic ingredients. 
The integration of data quality, kinetics and mechanistic modelling is a challenge, of 
course, and, furthermore, the precise manner in which this is carried out will depend 
strongly on individual scenarios. In general, the aim of predictive toxicology strategies is 
to combine all available knowledge to obtain the most plausible prediction for the 
relevant compound, so issues such as toxicity, safety, risk and exposure can be addressed 
properly, e.g. bans/limits of chemicals for certain applications. Risk assessment uses a 
variety of data from hazard and exposure, as well as use case, to make a decision. 
Traditionally these data include information from animal tests (e.g. NOAEL). As this 
type of testing is not acceptable anymore, at least not for novel cosmetic ingredients, new 
strategies will need to be applied. The development of a model predicting NOAEL values 
for all relevant biological endpoints and all types of organic chemicals in a near future is 
rather unlikely. Nevertheless, when going more into detail, plenty of useful tools and 
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strategies have been proposed – not only within this thesis. Since statistical and 
individual assessment of data quality contributes to higher certainty, more robust models 
and read-across approaches can be built and employed. This benefits the confidence in 
the obtained prediction. Furthermore, predictive models within a specific applicability 
domain of interest, e.g. a chemical family and their relation towards biological effects, 
can be expressed in a mechanistically more transparent fashion. Added to this, expert 
knowledge and computational tools dealing with ADME properties will predict uptake 
(e.g. dermal absorption), distribution, potential metabolites and elimination rates. Last, 
but not least, category formation, supported by screening tools, docking etc., may help to 
build local QSARs or binary data systems (e.g. toxic, non-toxic). Whilst consensus 
approaches employing different prediction tools (for example as demonstrated in Norlen 
et al. (2014)) can be used to predict the same endpoint, integration in the context of this 
discussion rather means the combination of different endpoints or effects, such as dermal 
absorption, mitochondrial toxicity, NR affinity etc., to support or reject a complete 
toxicological hypothesis, e.g. low doses of the compound administered dermally may 
trigger lipid accumulation in hepatocytes. The integration of multiple datasets and 
methods and the interpretation of the predictions are complex endeavours, which still 
demand toxicological expertise. Therefore the integration, as it is discussed in this thesis, 
is far from an automated predictive toxicology tool, which just needs to be fed with data 
and provides results ready for the use of regulatory authorities. 
 
8.2. Future of risk assessment 
Due to the complex chemical exposure scenarios of modern humans, risk and safety 
assessment is – and most likely will stay – a challenging task. Consumer goods of all 
kinds are designed and marketed worldwide. Beside a general lack of (high quality) 
toxicological and pharmacological data, it is difficult to consider individual contributing 
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factors, such as potential adverse effects due to polymorphisms or due to synergy of 
different ingredients. With the new legislation, the lack of traditional toxicology data is 
becoming greater, which creates a big challenge for regulatory toxicologists. What 
initially appears to be a setback for regulators, the ban of animal tests for cosmetics and 
cosmetics ingredients in the European market, appears to be an advantage on further 
consideration. Whilst NOAEL and LOEL data are used to determine toxicity (with huge 
variability according to Gottmann et al., 2001), mechanistic knowledge is often not 
incorporated. Furthermore Lewis et al. (2002) described many potential flaws in the way 
toxicity data, such as NOAEL values, are generated. These flaws are, for example, a lack 
of definitions of toxicology terms and inconsistent interpretations of such. Even 
histopathological data, if retrieved at all, are often not enough to identify or comprehend 
toxicity-driving MoAs. Since the information historically obtained by in vivo testing must 
be replaced somehow, it is necessary to focus on the advances of in vitro and in silico 
technologies. 
Of course in this thesis the focus lies on computational, non-testing strategies. Modern in 
silico tools often directly, or indirectly, employ, or can be used to gain, insights into 
mechanistic knowledge, i.e. information regarding enzymatic inhibition, receptor binding, 
electrophilic attack of DNA or proteins etc. Whereas local QSARs, docking, structural 
alerts and other screening tools often have direct associations with a single mechanism, 
machine learning approaches may be used to gain insights into mechanisms of action if 
their predictions can be interpreted in terms of the contributions of individual molecular 
features, as described by Palczewska et al. (2013). Furthermore, ADME- and PBPK-
modelling provides answers regarding the localisation and enrichment of compounds 
(refer to target organ toxicity) and the nature of the chemical species reaching the site of 
biological action (which may be affected by metabolism of the original chemical). Hence, 
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integration of kinetic and mechanistic modelling may benefit regulatory toxicology, 
which has been up until now dominated by in vivo testing. In non-testing strategies, 
regulatory toxicology is dominated by read-across approaches, at least for systemic 
toxicity. In addition to the purely computational tools described, in vitro assays may 
benefit predictions and hence toxicological assessments. By integration of multiple in 
vitro and in silico tests (refer to Integrated Testing Strategies) the joined information may 
support kinetic or mechanistic hypotheses. On the one hand it is a philosophical question 
to what extent tests need to be conducted to obtain satisfactory information, on the other 
hand it is a quite practical question as well. However, without neglecting the limitations 
of in vitro assays as compared to in vivo tests, it should be pointed out that the similar 
considerations are applicable to in vivo testing, for example when deciding on species, 
sex, dose pattern etc., and, as just as importantly, what analysis and histopathological 
investigations to perform (Hartung et al., 2013). Driven by the costs of testing and the 
plethora of chemicals and mixtures, the philosophical question has to turn into a 
pragmatic question to obtain a pragmatic answer regarding potential risks. 
Beyond setting the scene of the current, the alleged turning point of risk and safety 
assessment influenced by 21st Century Toxicology and the increase of ethical concerns, it 
is not clear to what extent risk and safety assessment will change and if the new paradigm 
will be sustainable. However, given the ever increasing number of new chemicals 
submitted to regulators for market approval, even if risk assessment processes have a 
very low error rate, it seems inevitable that some high risk chemicals may still make it 
onto the market. Particularly under capitalism, which urges the launch of novel products, 
it may be only a question of time when the next “chemical catastrophe” happens. 
Insufficiently assessed drugs, such as thalidomide (Dally, 1998) or 
fenfluramine/phentermine (Surapaneni et al., 2011), or food adulterants, such as 
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melamine in milk (Wu and Zhang, 2013) or tricresyl phosphate in ginger extract (Morgan 
and Penovich, 1978), may change the attitude of the public (and hence politicians), which 
may lead to more toxicological vigilance regarding risk and fewer ethical concerns 
regarding animal trials. Whatever will happen in 21st century regarding regulatory 
toxicology is difficult to predict. Of course politics play an important role regarding 
toxicological decision-making. However, it us up to scientists, particulary young 
scientists from the “digital native” generation, to face current challenges and influence 
policy makers and public opinion towards careful, but also feasible and sensible, 
assessment of chemicals, such as cosmetic ingredients. Technological development is 
moving on a fast pace – many tools we use nowadays naturally have been advanced 
technologies, with limited access, a few decades ago. The trend of freeware, open-access 
databases and transparent programming is contributing in silico toxicology massively. 
21st Century Toxicology has already brought many new insights, not only to me, but to 
the whole scientific community, and there are still some years to come. 
 
8.3. Conclusions 
The work presented in this thesis on statistical data quality, kinetics, i.e. skin permeability 
and dermal absorption, and mechanistically based modelling (hepatotoxicity alerts and 
prediction of NR-associated hepatosteatosis) are pieces designed to be integrated into 
modern toxicological risk and safety assessment. In particular, the work in this thesis 
should support risk assessment in the field of cosmetic ingredients. As opposed to many 
current achievements in predictive toxicology, transparency and flexibility of models and 
tools are strengths of this thesis as compared to statistical performance. Tools, methods 
and strategies are published and proposed respectively within this thesis and the 
associated scientific articles (refer to Appendix D). Beyond cosmetics, beneficial usage 
within other disciplines, for example pharmacology, is discussed in many chapters. The 
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overall aim was to propose ideas regarding how to build and interpret new models, and of 
course how to use them in combination (refer to consensus approach) with a focus on 
safety assessment in the consumer care industry. More specifically, a method for 
calculating statistical data quality (to improve QSAR modelling and other computational 
approaches), new models for skin permeability / dermal absorption, screening tools for 
NR-binding and hepatotoxicity structural alerts have been created. All these models and 
tools have the potential to support toxicological evaluations and regulatory decision-
making directly. However, the methodologies used in development of the tools and 
models might support regulatory toxicology even more indirectly. The transparent design 
of workflows (mostly within KNIME) and statistics, the usage of freeware (e.g. R, 
Toxmatch) and the usage of open-access data (e.g. ChEMBL, PDB) will give 
toxicologists and regulators the opportunity to adjust tools and models towards their 
relevant problems. In a nutshell, the aim of novel but transparent in silico tools and 
models to support the assessment of cosmetics ingredients can be regarded as 
accomplished on multiple levels. 
 
8.4. Future work 
As described earlier (refer to Chapter 1), toxicology is a great field with far too many 
chemicals, endpoints etc. to ever fully elucidate this discipline. Even restricting ourselves 
to particular aspects of this field, such as the topics investigated within this thesis, it 
seems to be an almost endless story. From protein interactions to pathological pathways, 
a lot of things are not currently as clear and understandable as they should be. Biological 
data are often not of the necessary data quality (refer to Chapters 2 and 3), probably due 
to the complexity of biomolecular assays, which makes toxicological interpretation rather 
difficult. Tendencies as described in skin permeability / dermal absorption (Chapters 3 
and 4) or in NR-related mechanistic modelling (Chapters 5, 6 and 7) are used for 
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predictions. When considering all those possible influences, such as metabolism or active 
transport, predictions led purely by toxicologically relevant properties cannot always be 
correct. So, there is still plenty room to improve, but this is difficult due to a lack of data 
and hence a lack of understanding. Nevertheless, predictive toxicology is of great 
importance for many different areas, although there are limiting factors, such as the many 
unknown mechanisms and, of course, the limited availability of data. The most limiting 
factor probably is, and always will be, the complexity of the human body. However, even 
if not perfectly, it is likely that QSARs and AOPs will join to quantitative AOPs ready for 
endpoint- and MoA-specific predictions in the near future. They will have the great 
advantage of transparency compared to global, endpoint-specific QSAR models, which 
do not account for mechanistic information. 
As mentioned earlier, it is unlikely that automated model development will deal with 
toxicological issues in the near future. The development of a predictive toxicology tool, 
which just needs to be fed with data and spits out results ready for use, is not foreseeable. 
But, that is not all bad news. The good news is that many computational toxicologists can 
follow up in this interesting field, probably for many decades, or even centuries, to come. 
Particularly as data, descriptors and knowledge constantly increase (and even sometimes 
change), there could be many full-time jobs created for computational toxicologists, just 
for updating and refining already existing models. Despite this endeavour, there is still 
the potential for real novelties which might be based on new 
pharmacological/toxicological insights (e.g. new AOPs) or the combination of different 
technologies (e.g. combining QSPRs with PBPK-models). However, all these approaches 
have the potential to create game-changing models and affect the way regulatory 
toxicologists approach the challenges of tomorrow.  
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10. Appendices 
The appendices contain data tables (A), rules and SMARTS patterns (B), codes and 
workflows (C) and published works (D). Except the published works, i.e. relevant 
authored and co-authored articles and abstracts in appendix D, the appendix is not paper-
based. However, all appendices can be found in the attached USB card.  
 
A    Data tables 
All datasets used in these studies are available on the USB card attached to this thesis. 
 
A.1 Microtox dataset (including exposure comparison) 
(refer to attached USB card) 
 
A.2 Microtox and skin permeability dataset (including statistical equations) 
(refer to attached USB card) 
 
A.3 Dermal absorption dataset 
(refer to attached USB card) 
 
A.4 RAR ligand dataset 
(refer to attached USB card) 
 
A.5 NR ligand dataset (including RAR/RXR, PPAR, LXR and FXR) 
(refer to attached USB card) 
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B    Rules and SMARTS patterns 
All rules and SMARTS patterns used in these studies are available electronicallly. 
 
B.1 Hepatotoxicity structural alerts “Hewitt & Steinmetz” 
(refer to attached USB card) 
 
B.2 Rules for RAR ligand screening 
(refer to attached USB card) 
 
B.3 Rules for NR ligand screening (RAR/RXR, PPAR, LXR and FXR) 
(refer to attached USB card) 
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C    Codes and workflows 
All codes and workflows used in these studies are available electronically. 
 
C.1  KNIME workflow for RAR ligand screening 
(refer to attached USB card) 
 
C.2  R-code for RMSECS (10-fold crossvalidation for CS-weighted multivariate 
linear regression) 
(refer to attached USB card) 
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D    Published Works 
All relevant articles and conference abstracts published within this PhD as main author 
(or co-author with significant contribution) are presented on the following pages. 
 
D.1  Steinmetz et al. Sci. Total Environ. 482 (2014), 358-365 
 
D.2  Steinmetz et al. Mol. Inform. 34 (2015), 171-178 
 
D.3  Steinmetz et al. J. Chem. Inf. Model. 55 (2015), 1739-1746 
 
D.4  Mellor et al. Toxicology Letters 229 (2014), 162 
 
D.5  Cronin et al. Altex Proceedings 1/14 (2014), 69 
 
D.6  Cronin et al. Toxicology Letters S238 (2015), 166 
 
D.7  Steinmetz et al. Toxicology Letters S238 (2015), 166 
 
D.8  Richarz et al. Toxicology Letters S238 (2015), 166 
 
D.9  Richarz et al. Toxicology Letters S238 (2015), 170 
 
D.10 Tsakovska et al. Toxicology Letters S238 (2015), 173 
 
D.11 Mellor et al. (2015) Crit. Rev. Toxicol. (early online: 1-15)  
 
 
 
